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Abstract
Öster, L., 2005. Structure-Function Studies of β-lactam Biosynthetic  Enzymes. Doctoral
dissertation.
ISSN 1652-6880, ISBN 91-576-7000-5.
β-lactam  compounds  belong  to  the  most  important  antibiotics  in  current  use.  The
increasing  occurrence  of  bacterial  resistance  against  antibiotics,  which  threatens  to
move us back to pre-antibiotic  era, calls  for  the  development  of  new  antibiotics.  β-
lactams are produced by fermentation in the microorganism, therefore knowledge about
the biosynthetic  enzymes involved  is vital  for the  production  of  new  antibiotics  to
escape resistance. This thesis presents structure-function studies  on enzymes involved
in the biosynthesis of the β-lactam antibiotics cephalosporins and cephamycins
DAOCS is a non-heme  Fe(II) dioxygenase  and catalyses  the oxidative  ring  expansion
of the penicillin nucleus into the nucleus of cephalosporins. Structures of  DAOCS with
substrates,  product  and  cofactors  obtained  from  two  different  crystal  forms  are
presented here. The structural results suggest a mechanism for cephalosporin  formation
where 2-oxoglutarate  and dioxygen  need to react  first  to  produce  an  oxidizing  iron
species, followed by reaction with the penicillin substrate. Structural  differences in the
two crystal forms indicate conformational  flexibility  in the C terminus  and point  to a
role for the C terminus in catalysis.
Biosynthesis  of cephamycins  (C7-methoxylated  cephalosporins)  is catalysed  by  two
enzymes, cmcI and cmcJ, but  the details  of catalysis  are largely  unknown.  The crystal
structure  of cmcI, presented  here,  is  a  hexamer  consisting  of  a  C-terminal  Rossman
domain  and  a  smaller  N-terminal  domain.  The  N-terminal  domain  is  involved  in
oligomerisation and the Rossmann domain binds  SAM and SAH in a fashion  common
for  methyltransferases,  with  a  bound  magnesium  ion  in  the  vicinity  of  SAM.  The
expected cephalosporin binding site is occupied by PEG, which  ligates  the magnesium
ion.  From  docking  studies  of  a  cephalosoporin  molecule  to  the  cmcI-Mg
2+-SAM
structure,  a model for substrate  binding  is proposed.  Altogether,  the  results  suggest
cmcI  is  a  methyltransferase  that  catalyses  the  second  catalytic  step  in  cephamycin
biosynthesis.
Keywords:  β-lactam antibiotics,  2-oxoglutarate  dependent  dioxygenases,  cephamycin
biosynthesis,  protein  crystallography,  Streptomyces  clavuligerus,
deacetoxycephalosporin C Synthase, cmcI
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2ODD 2-oxoglutarate dependent dioxygenase
6-APA 6-aminopenicillianic acid
7-ACA 7-aminocephalosporanic acid
ACVS δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine synthetase
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MAD multiple-wavelength anomalous diffraction
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1. Introduction
At the beginning of the 1900’s bacterial infectious diseases such as pneumonia and
tuberculosis were among the leading causes of death worldwide. This  is  hard  to
imagine  today  with  all  available  drugs,  but  without  any  antibiotics,  a  simple
bacterial infection could be fatal. After the successful development  of  antibiotics
such as penicillin in the 1940s, victory against  bacterial  infectious  diseases  was
declared.  However,  new  infectious  diseases  and  in  particular  the  increasing
bacterial resistance against antibiotics, leading to the re-emergence of diseases once
controlled, have forced us to revaluate that  statement.  Today bacterial  infections
are once again identified as one of the greatest  threats  to  human  health  (Cohen,
2000).
Antibiotics (Greek anti, against, and bios, life) are naturally occurring  microbial
products or their derivatives that exhibit bacteriostatic or bactericidal  effects,  i.e.
they inhibit or kill bacteria without harm to  the  eukaryotic  host  harbouring  the
infecting bacteria. Antibiotics belong to a group of  compounds  called  secondary
metabolites,  generally  characterised  by  being  produced  at  low  specific  growth
rates, and not being essential for the producing organism (bacteria or fungi) in pure
culture.  However,  antibiotics  are  critical  to  the  organism  in  their  natural
environment both for their survival  and  as  a  competitive  advantage  (Demain  &
Fang, 2000). The antibiotics are used as chemical weapons to kill other microbes
in the surrounding microenvironment.
Over the years, most antibiotics have  been  discovered  by  screening  of  e.g.  soil
samples  and  marine  environments  for  natural  products  that  kill  bacteria.  The
synthesis of these compounds poses a very complex and demanding task for  the
organic synthetic chemist and the yield, if any, is  mostly  extremely  low.  Large
scale  commercial  synthesis  is  uneconomical  and  rarely  a  possibility.  Instead,
fermentation  of  the  bacterial  or  fungal  strains  followed  by  extraction  and
purification of the compounds  is  the  common  method  to  obtain  antibiotics  for
commercial use. Frequently,  chemical  modifications  of  the  natural  products,  so
called semi-synthetic modifications, are employed to obtain new variants that are
more effective and/or better suited as drugs.
To  prevent  the  same situation  as  in  the  beginning  of  the  twentieth  century  to
occur, it is vital to develop a more sensible use of antibiotics as drugs and ban the
use of antibiotics as growth promoters in  agriculture.  Since  most  antibiotics  in
current use are derived from a rather small number of basic compounds and very
few  new  antibiotics  are  presently  approved  for  clinical  use  (Breithaupt,  1999),
there is also a great need to expand the antibiotic repertoire and  to  produce  new
antibiotic variants not yet encountered by bacteria. In addition, cheaper and more
environmentally friendly  routes  to  already  existing  compounds  are  required  for
industrial production. To meet these needs, one way may be to study in detail the
micro-organisms that  produce  antibiotics  and  to  use  their  present  machinery  or
modify it for novel antibiotic production.10
1.1 β-lactam antibiotics
The discovery and development of the  β-lactam  antibiotics  are  among  the  most
powerful  and  successful  achievements  of  modern  science  and  technology.  In
particular penicillins and cephalosporins represent the world's major biotechnology
products with worldwide sales of ~ US$ 15 billion per year or ~ 65% of the total
world market for antibiotics (Elander, 2003).
1.1.1 History - the discovery of penicillins, cephalosporins and
cephamycins
Penicillins
In  1928  in  London,  Alexander  Fleming  by  chance  discovered  that  Penicillium
notatum spores  could  lyse  colonies  of  staphylococci  and  that  the  active  factor,
which he gave the name penicillin, could be  found  in  the  filtrate  of  the  mould
culture (Fleming, 1929). There were no further breakthroughs until in 1940, when
Howard Florey and Ernst Chain undertook detailed studies of penicillin in Oxford.
They demonstrated its chemotherapeutic activity in mice and confirmed its lack of
toxicity (Florey et al., 1949). Production of penicillin by the strain of Penicillium
notatum was very slow and it took long before the first successful clinical tests on
humans could be performed. The need for large-scale production was essential but
due to World War II, this could not be done in England. Instead,  collaborations
with  pharmaceutical  companies  in  the  U.S.A.  led  to  strain  improvements  and
medium modifications which increased the yield of penicillin 100-fold within two
years. Eventually, in 1943 penicillin G (benzylpenicillin) was used to successfully
treat those wounded in the war. Since then a number of different penicillins have
been  discovered  and  used  in  the  clinic.  In  1945  Fleming,  Florey  and  Chain
received the Nobel Prize for the discovery and production of penicillin.
Cephalosporins
Following the discovery of penicillin,  a  range  of  naturally occurring  antibiotics
were discovered. In Sardinia, Giuseppi Brotzu isolated a strain of Cephalosporium
acremonium (now called Acremonium chrysogenum) from seawater near a  sewage
outfall in  1945.  The strain  secreted  material  with  activity  against  a  number of
Gram-positive and Gram-negative bacteria (Brotzu, 1948). Brotzu had neither the
facilities nor the expertise to carry his work further, so a culture of the fungus was
sent to Howard Florey in Oxford. A number of different β-lactam antibiotics were
isolated and analyzed (Burton & Abraham, 1951). Among the most important was
penicillin N, a new penicillin with a hydrophilic side  chain  that  showed  greater
activity  against  Gram-negative  bacteria  compared  to  the  currently  known
penicillins  with  hydrophobic  side  chains.  Another  new  discovery  was
cephalosporin  C,  which  showed  a  rather  low  antibacterial  activity  compared  to
penicillins, but was stable in the presence of penicillin β-lactamases (β-lactamases
are  β-lactam  hydrolysing  enzymes  which  at  that  time  had  become  a  serious
problem).  The  low  potency  of  cephalosporin  C  was  soon  overcome  by  the
introduction  of  semi-synthetic  modifications,  resulting  in  a  great  number  of
different cephalosporins in clinical use.11
Cephamycins
Initially, it was believed that only fungi  produced  β-lactams. However,  a  report
from  Merck  &  Co.  in  the  early  1960s,  stated  that  a  strain  of  streptomycetes
produced penicillin N (Miller et al., 1962). Further work at Merck and Eli Lilly &
Co.  showed  that  various  species  of  Streptomyces  and  Nocardia  produced
cephalosporins modified at C7 (cephamycins) and/or at the side chain attached to
C3 (for numbering see Figure 1.2) (Nagarajan et al., 1971; Stapley et al., 1972).
The discovery of cephamycin C led to research on and development of prokaryotic
cephalosporins. The presence of the methoxy group on the β-lactam ring made the
molecule more active  against  Gram-negative  and  anaerobic  pathogens and  more
resistant  to  Gram-negative  β-lactamases  (Stapley  et  al.,  1979)  compared  to  the
existing β-lactams. Like fungal cephalosporin C,  cephamycin  C  was  never  used
clinically  but  was  employed  for  semi-synthesis  of  many  medicinally  useful
compounds.
1.1.2 Chemistry
The three-dimensional structure of penicillin was determined in the mid-1940s by
Dorothy Hodgkin in her pioneering X-ray crystallographic work (Crowfoot et al.,
1949).  All  penicillins  are  chemically  characterised  by  the  presence  of  a  four-
membered heterocyclic ring, the β-lactam ring, which is fused to a five-membered
thiazolidine (penam) ring (Figure 1.1).
Variants of penicillin contain different acyl side chains (R1) attached by an amide
linkage to the amino group of the penicillin nucleus, named  6-aminopenicillanic
acid (6-APA).
In cephalosporins, the four-membered β-lactam  ring  is  fused  to  a  six-membered
dihydrothiazine (cephem) ring (Figure 1.2). There are many different variations of
cephalosporins with different side-chains at R1 and R2 of the cephalosporin nucleus
7-aminocephalosporanic acid (7-ACA).
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Figure 1.1 The structure of the
penicillin  core:
6-aminopenicillanic acid (6-APA).
Figure 1.2 The structure of the
cephalosporin  core:
7-aminocephalosporanic acid (7-ACA).12
β-Lactams are conventionally numbered using the ring-sulphur as  position-1;  for
penicillins and cephalosporins the numbering is illustrated in figures 1.1 and 1.2,
respectively.  Substituents  on  the  bicyclic  systems  are  usually  described  by  the
prefix α- or β- rather than the exo and endo notation.
The cephamycins  differ  from  the  cephalosporins  in  the  presence  of  a  methoxyl
group at the C7-position (Figure 1.3).
Since  the  discovery  of  cephamycins,  a  number  of  other  groups  of  β-lactam
antibiotics have been found, many of clinical importance. Common to all of these
is the β-lactam ring. Variations are achieved by alteration to the core of the five or
six-membered rings, see Figure 1.4.
Figure 1.4 Core structures of major classes of β-lactam compounds.
Further variations of the β-lactams can be achieved by altering the  different  side
chains at the R1 and/or R2 positions. By these variations, different compounds can
be made that exhibit different antibiotic activity and spectrum and also influence
the  solubility  and  stability  of  the  compound.  Some  of  these  variations  are
naturally  synthesized  but  many  are  made  by  semi-synthetic  modifications  of
fermented material, see Figure 1.5 for some examples.
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Figure 1.5 Examples of β-lactam antibiotics.
1.1.3 Mechanism of action
β-Lactams exert their lethal action on growing bacterial cells only. The addition of
the  antibiotic  to  a  sensitive  strain  usually  results  in  cell  lysis,  but  the  actual
mechanism of  killing  is  not  entirely understood  (Bayles,  2000).  The  β-lactam
antibiotics interfere with the bacterial cell wall synthesis by inhibiting  penicillin
binding proteins (PBPs), also called DD-transpeptidases (Matagne et  al.,  1999).
PBP's  are  membrane-bound  enzymes  that  catalyze  the  cross-linking  of
peptidoglycan polymers in the peptidoglycan synthesis. The peptidoglycan  is  an
essential component of the bacterial cell wall with no equivalence in the eukaryotic
world. The bacterial cell wall protects and determines the shape of the organism.
The β-lactams acts as pseudosubstrates of the PBP's and the β-lactam ring acylates
their active site serine, and forms a stable covalent acyl-enzyme complex (Figure
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1.6).  The inactivation  of  the  PBP's  eventually  leads to  a  cell  wall  unable  to
withstand osmotic forces and bacteriolysis occurs.
Figure 1.6 Interaction between the β-lactam antibiotics and the active site  serine of the
PBP, resulting in a stable acyl-enzyme complex.
1.1.4 Resistance
Already in 1940’s, resistance to penicillin in some strains of E. coli was noted by
Abraham  and  Chain  (Abraham  &  Chain,  1940).  During  the  1950’s,  resistance
became a serious problem as the staphylococcal population had built up resistance
to penicillins via selection of penicillin β-lactamase-producing strains.
Bacteria have several strategies to escape the activity of antibiotics (Walsh, 2000):
enzymatic destruction, target site (PBP)  alterations,  diminished  permeability for
the drug to enter the cell, and active efflux systems that pump the drug out of the
cell. Bacteria utilise all to fight β-lactams, but the most common and well-known
mechanism is the enzymatic destruction via synthesis of β-lactamases. This group
of  enzymes  hydrolyse  the  essential  β-lactam  ring  (Figure  1.7),  thus  precluding
further reactions with PBPs.
Figure 1.7 The hydrolysis of the β-lactam ring by β-lactamases.
The β-lactamases are secreted into the periplasm in Gram-negative bacteria and to
the outer medium in Gram-positive species to destroy β-lactam antibiotics before
they can reach the PBP  targets  in  the  cytoplasmic  membrane.  β-Lactamases  are
structurally related to PBPs and have probably evolved from them (Poole, 2004).
Several hundred β-lactamases have now been  identified  and  have  been  classified
into four groups: A, B, C  and  D.  Of  these,  the  class  B  β-lactamases  are  zinc-
dependent enzymes and the remaining (A, C and D) are serine hydrolases.
During  the  years,  two  main  strategies  have  been  employed  to  circumvent  the
resistance  caused  by  β-lactamases.  The  first  one  involves  alterations  of  the
structure of the β-lactam core (Figure 1.5) to produce new variants not recognized
by the β-lactamases. Unfortunately, it is usually only a question of time  until  a
new mutation allows a modified β-lactamase to recognize and hydrolyse the new
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compound.  The  other  strategy  involves  inhibition  of  the  β-lactamases.  One
example is clavulanic acid,  a  naturally occurring  β-lactam  (Figure  1.5)  that  has
little antibacterial activity in itself but binds the β-lactamases irreversibly  and  is
used together with β-lactam antibiotics (Walsh, 2000).  However,  clavulanic  acid
does not inhibit all β-lactamases.
1.2 Biosynthesis of β-lactam antibiotics
Filamentous  fungi  such  as  Penicillium  chrysogenum  and  Cephalosporium
acremonium only  produce  β-lactam  antibiotics  with  penicillin  or  cephalosporin
structure  whereas  bacteria  such  as  Streptomyces  clavuligerus  and  Amycolatopsis
lactamdurans  synthesize  a  wider  variety  of  β-lactam  structures  including
cephamycins,  clavams,  carbapenems  and  monobactams  etc.  The  penicillins,
cephalosporins  and  cephamycins  share  the  same  biosynthetic  pathway  starting
from  three  amino  acids.  Their  biosynthesis  differs  from  the  biosynthesis  of
clavams,  carbapenems  and  monobactams,  which  are  synthesised  from  different
precursors via  different  biosynthetic  pathways,  although  they  all  contain  the  β-
lactam ring.
The enzymes studied in this thesis are  from  Streptomyces  clavuligerus,  a  gram-
positive bacterium that belongs to the family of actinomycetes. The actinomycetes
are  mycelially  growing,  filamentous  fungal-like  bacteria  that  grow  in  soil.  Of
these,  species  of  Streptomyces  are  known  as  some  of  the  best  producers  of
secondary  metabolites,  including  antibiotics.  Two  Streptomyces  genomes,  S.
coelicolor (Bentley et al., 2002) and S. avermitilis (Ikeda et al., 2003), have been
sequenced, revealing very large genomes for bacterial standards (8.8 Mbp and 9.0
Mbp) with many protein coding sequences and a high G + C content (>70%). A
relatively  large  percentage  of  the  protein  coding  sequences  (4.5  and  6%)  are
predicted to encode biosynthetic enzymes involved in the production of secondary
metabolites. These genes usually seem to cluster.
  
1.2.1 The cephamycin gene cluster in Streptomyces clavuligerus
In  addition  to  the  genes  encoding  the  biosynthetic  enzymes,  the  β-lactam
producing clusters usually also contain accessory genes necessary for the antibiotic
production. Such accessory genes are of three types: resistance genes that  encode
for  the  machinery  by  which  the  host  protects  itself  from  the  antibiotic  being
produced, export genes that transport the antibiotic outside the cell, and regulatory
genes that control the expression of genes in the cluster.16
The genes responsible for cephamycin biosynthesis in S. clavuligerus are clustered
(Figure 1.8) and have been estimated to comprise approximately 38 kb (Alexander
& Jensen, 1998). The cluster is depicted in Figure 1.8, with the genes encoding
the  biosynthetic  enzymes  marked  with  stars,  the  other belong  to  the  accessory
genes.  
Figure 1.8 The Cephamycin  gene cluster  in Streptomyces  clavuligerus with the genes
encoding biosynthetic enzymes marked with stars.
1.2.2 The biosynthesis of penicillins, cephalosporins and cephamycins
The biosynthetic routes described here  are  outlined  in  Figure  1.9.  The pathway
starts  with  the  condensation  of  three  L-amino  acids:  L-α-aminoadipic acid,  L-
cysteine  and  L-valine  with  a  configurational  inversion  of  L-valine  to  form  the
linear tripeptide δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine (ACV). This is a  non-
ribosomal  peptide  biosynthesis  catalysed  by  a  single  multifunctional  enzyme,
ACV synthetase (ACVS) (Byford et al., 1997), which requires Mg
2+ and ATP for
activity.
In  the  next  step,  the  ACV  tripeptide  is  cyclized  by  isopenicillin  N  synthase
(IPNS),  to  give  isopenicillin  N,  a  β-lactam  compound  with  weak  antibiotic
activity  which  is  the  precursor  of  all  penicillin  and  cephalosporin  antibiotics
(Baldwin  &  Schofield,  1992).  IPNS  is  a  38  kDa  enzyme  that  uses  Fe(II)  and
molecular oxygen as cofactors.  IPNS  belongs  to  the  family  of  non-heme  Fe(II)
oxygenases and cyclizes ACV by the removal of  four  hydrogens  to  form  water.
The crystal structure of IPNS from Aspergillus nidulans, the first structure of an
enzyme from this family, was solved in 1995 (Roach et al.,  1995).  Since  then,
there have been a number of high-resolution structures  of  substrate,  product and
intermediates published that have lead to detailed knowledge of the mechanism of
IPNS (Roach et al., 1997; Burzlaff et al., 1999).
After the formation of isopenicillin N, there is a branch point between organisms
producing cephalosporins and those producing penicillins only. The product of the
next step in cephalosporin producers, penicillin N, which has not been  found  in
any  penicillin-only  producers  (Baldwin  &  Schofield,  1992),  is  formed  from
isopenicillin N in an epimerisation reaction catalysed by isopenicillin N/penicillin
N epimerase (Jensen et al., 1983).
bla  pbpA     cmcT   pcd  cefE     cmcI        cefF               ccaR          blp          pcbAB                  pcbR
                                                cefD       cmcJ       cmcH             orf11        lat    pcbC
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Figure 1.9 The biosynthetic pathway of penicillin, cephalosporin and cephamycin.
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In  penicillin-producing  fungi  that  do  not  synthesize  cephalosporins  (i.e
Penicillium chrysogenum),  the  final  reaction  is  catalyzed  by  the  acyl  coenzyme
A:isopenicillin  N  acyltransferase  (IAT)  (Brakhage,  1998).  This  enzyme  has  not
been  found  in  bacteria.  In  this  step  the  hydrophilic  L-α-AAA  side-chain  is
exchanged for a hydrophobic acyl group, e.g.  phenylacetyl  in  penicillin  G.  IAT
shows  broad  substrate specificity  (Luengo,  1995)  and  during  fermentation  the
synthesis can be directed toward a specific penicillin by the addition of appropriate
precursor molecules.
In  cephalosporin  producing organisms,  the  five-membered  thiazolidine  ring  of
penicillin N is expanded to the six-membered dihydrothiazine ring characteristic of
all  cephalosporin  antibiotics.  In  eukaryotic  cephalosporin  producers  (e.g.
Cephalosporium  acremonium), the  ring  expansion to  deacetoxycephalosporin  C
(DAOC) and a subsequent hydroxylation at C-3' to form deacetylcephalosporin C
(DAC) are catalysed by the  bifunctional  enzyme  deacetoxy/deacetylcephalosporin
synthase (DAOC/DACS). However, in prokaryotic  cephalosporin  producers  (e.g.
Streptomyces  clavuligerus) the  ring  expansion  and  hydroxylation  reactions  are
catalysed by two separate enzymes (Jensen et al., 1985), deacetoxycephalosporin C
synthase  (DAOCS)  and  deacetylcephalosporin  C  synthase  (DACS).  DAOCS,
DACS and DAOC/DACS are all dioxygenases requiring Fe(II), 2-oxoglutarate and
dioxygen to remove two electrons from the substrate, two from the co-substrate to
form  succinate,  CO2  and  water.  All  three  enzymes  show  a  high  sequence
homology (DAOCS and DACS, 59%; DAOCS and DAOC/DACS, 57%; DACS
and  DAOC/DACS,  54%).  The  structure  of  DAOCS  from  Streptomyces
clavuligerus  (Valegård et  al.,  1998)  was  solved  in  1998  and  will  be  further
discussed later in this thesis.
In the final step in cephalosporin C formation an acetyl moiety from acetyl-CoA is
transferred  to  the  hydroxyl  group  of  DAC.    This  step  is  catalyzed  by  acetyl-
CoA:DAC acetyltransferase  (Brakhage, 1998). DAC constitutes the second branch
point  in  the  biosynthesis,  dividing  the  pathways  for  cephalosporin  C  and
cephamycin C biosynthesis.
Cephamycin C  biosynthesis  has  so  far  only  been  reported  in  bacteria  such  as
Streptomyces clavuligerus and Amacolatopsis lactamdurans. In this  pathway  the
C-3  acetoxy  group  of  DAC  is  replaced  by  a  carbamoyl  group.  This  step  is
catalyzed by DAC-carbamoyl  transferase  and  requires  carbamoyl  phophate,  ATP
and  Mn
2+-  and  Mg
2+-ions  (Brewer  et  al.,  1980;  Coque  et  al.,  1995a).  The
biosynthetic  routes  leading  to  methoxylated  cephalosporin  (7-α-methoxy-
cephalosporin)  have  not  been  fully  elucidated  and  will  be  discussed  further  in
chapter 5 of this thesis.19
1.2.3 The biosynthesis of clavulanic acid
Clavulanic acid (Figure 1.5) is a β-lactam with weak antibacterial activity, but can
act  as  a  potent  serine  β-lactamase  inhibitor  (Baggaley  et  al.,  1997)  and  is
administrated in combination with penicillins in the clinic. Chemical synthesis of
clavulanic  acid  is  even  more complicated  than  the  synthesis  of  penicillins  and
cephalosporins  and  the  industrial  production  therefore  involves  fermentation  of
Streptomyces clavuligerus.
Biosynthesis  of  clavulanic  acid  and  other clavams  have  only  been  reported  in
species  of  Streptomyces (Baggaley et  al.,  1997).  Even  though  clavulanic  acid
shares the β-lactam ring with penicillins and cephalosporins it is synthesised via a
different pathway and from different precursors. The clavulanic acid gene cluster in
Streptomyces clavuligerus  contains  at  least  18  genes  (Ward  &  Hodgson,  1993;
Hodgson et al., 1995; Li et al., 2000; Mellado et al., 2002), lies adjacent to the
cephamycin gene cluster (Ward  &  Hodgson,  1993),  and  has  not  yet  been  fully
elucidated.
The pathway (Figure 1.10) starts with a condensation of the precursors L-arginine
and D-glyceraldehyde 3-phosphate to give N
2-(2-carboxyethyl)arginine catalysed by
N
2-(2-carboxyethyl)arginine synthase (CEAS) (Khaleeli et al., 1999; Caines et al.,
2004).  The next  enzyme,  β-lactam  synthetase  (β-LS)  (Bachmann et  al.,  1998),
catalyses the formation of the β-lactam ring via a mechanism completely distinct
from  the  IPNS-catalysed  formation  of  the  β-lactam  ring  of  penicillins  and
cephalosporins. β-LS shows the highest sequence and structural homology to class
B asparagine synthetases (Miller et al., 2001). The next enzyme in the pathway,
clavaminate synthase (CAS), a Fe(II)-2-oxoglutarate  dependent  dioxygenase  with
homology to IPNS and DAOCS, catalyses 3 distinct oxygenase reactions  in  the
biosynthesis  of  clavulanic  acid.  In  the  first  CAS  catalysed  reaction,  the
monocyclic  β-lactam  is  hydroxylated  to  give  a  secondary  alcohol:
guanidinoproclavaminic acid (Baldwin et al., 1993) (that is neither a substrate nor
an  inhibitor  of  CAS).  The following  step  is  catalysed  by  proclavaminic  acid
amidino  hydrolase  (PAH),  which  hydrolyses  the  guanidino  group  to  give
proclavaminic acid (Elkins et al., 2002a). Next, CAS mediates the  formation  of
the bicyclic nucleus of clavulanic acid in a two-step reaction involving oxidative
cyclization, followed by desaturation to form clavaminate (Baldwin et al., 1991;
Salowe et al., 1991). The structure  of  CAS  has  been  elucidated  (Zhang et  al.,
2000)  and  is  similar  to  that  of  DAOCS  and  IPNS.  So  far,  CAS  is  the  only
enzyme identified in the clavulanic acid pathway that bears similarities to enzymes
in the penicillin/cephalosporin pathway.
The pathway  beyond  clavaminate  is  not  well  characterized,  and  the  only  other
known  intermediate  between  clavaminate  and  clavulanic  acid  is  clavaldehyde
which is reduced in an NADPH-dependent reaction to clavulanic acid by the action
of clavulanic acid dehydrogenase (CAD) (Nicholson et al., 1994). The mechanism
by  which  clavaminate  undergoes  stereochemical  inversion  and  side  chain
modification to form clavaldehyde is unknown. There are yet many open reading
frames  (ORF)  in  the  clavulanic  acid  biosynthetic  gene  cluster  with  unassigned20
function. Biochemical and structural characterisation of these ORFs will be crucial
in understanding the biosynthesis of clavulanic acid.
Figure 1.10 Biosynthetic pathway leading to clavulanic acid.
1.2.4 Non-heme Fe(II) oxygenases
An observant reader might have noticed the somewhat over-representative number
of non-heme iron oxygenases involved in the biosynthesis of β-lactam antibiotics.
From  penicillin,  cephalosporin  and  cephamycin  biosynthesis,  IPNS,  DAOCS,
DACS, DAOC/DACS all belong to this group together with possibly yet another
enzyme in the late steps of cephamycin biosynthesis (discussed in chapter 5). For
clavulanic acid biosynthesis, the enzyme CAS that catalyses three distinct steps in
the synthesis also  belongs  to  this  family.  All  of  these except  IPNS  require  2-
oxoglutarate as a cofactor and  are  named  2-oxoglutarate  dependent  dioxygenases
(2ODDs).
This group of enzymes catalyse a variety of important oxidative reactions in many
organisms ranging from prokaryotes to eukaryotes. Many of the enzymes function
in  pathways  that  have  medical,  pharmaceutical  or  agricultural  importance,  and
several of them have been implicated in disease states (Hausinger, 2004). Several
structures  of  non-heme  Fe(II)  oxygenases  have  been  solved  and  will  be  further
discussed later in the thesis.  The enzymes  share  a  jelly  roll  fold  with  the  iron
ligated  by  a  2-His-1-Asp/Glu  motif  (the 2-His-1-carboxylate  facial  triad  motif)
(Schofield  &  Zhang,  1999).  Even  if  the  crystal  structures  together  with
spectroscopic  studies  have  increased  the  knowledge  of  the  mechanism of  these
enzymes significantly, there is still much left to learn, in particular regarding the
Glyceraldehyde 3-phosphate
+
Arginine
CEAS HO2C HN
N
H
NH2
NH
CO2H
N
H
NH2
NH
CO2H
N
O
BLS
CAS
N
H
NH2
NH
CO2H
N
O
OH PAH
NH2
CO2H
N
O
OH CAS
N
O
O
CO2H
NH2
N
O
O
CO2H
NH2
CAS
? ?
N
O
O
CO2H
O
N
O
O
CO2H
OH
N2-(2-carboxyethyl)-arginine deoxyguanidino proclavaminic acid
guanidino proclavaminic acid proclavaminic acid dihydroclavaminic acid
clavaminic acid clavaldehyde
CAD
clavulanic acid21
reaction  with  oxygen.  The enzymes  are  thought  to  function  through  a  highly
oxidising iron(IV) species, the ferryl, but as yet the only evidence for the ferryl is
through detection by spectroscopy of a ferryl intermediate in the reaction catalysed
by taurine/α-ketoglutarate dioxygenase, TauD (Proshlyakov et al., 2004). A more
complete understanding of the catalysis performed by these versatile mononuclear
ferrous enzymes would be significant in scientific, medicinal and industrial terms.   
1.3 Industrial production of β-lactam antibiotics
Although most β-lactam antibiotics in clinical use can be synthesized chemically
at low yields, this procedure is far too expensive and complicated for commercial
use. Instead, fermentation and semi-synthetic modifications are the preferred ways
to  obtain  β-lactams  on  a  large  scale.  Today,  fermentation  is  a  very  modern
procedure giving high yields to a moderate cost (Elander, 2003), in particular with
penicillins.  However,  there  is  still  plenty  of  room  for  optimisations  and
developments, not at least in an environmental perspective since the procedure is
very dirty and creates lots of waste products. With the increasing resistance against
β-lactams there is also a great need to develop new antibiotics.
1.3.1 Penicillins
Penicillin V and penicillin G are the only natural penicillins in clinical use. They
are  obtained  by  varying  the  precursors  added  to  the  fermentation  broth  of
Penicillium chrysogenum; phenylacetic acid for penicillin G or phenoxyacetic acid
for penicillin V. However, the majority of penicillins used today are obtained by
semi-synthetic modifications of  the  penicillin  core,  6-aminopenicillanic  acid  (6-
APA), Figure 1.1. 6-APA used to be obtained by a chemical splitting technique of
fermented  penicillin  but  due  to  environmental  pollution  and  high  costs  the
preferred method today is enzymatic conversion using penicillin G- or V  acylase
(Arroyo et  al.,  2002).  Recent  structural  and  site-directed  mutational  studies  on
different β-lactam acylases have lead to better yields and also to the possibilities to
alter  the  substrates  and  use  the  acylases  to  synthesise  semi-synthetic  β-lactam
antibiotics (Sio & Quax, 2004).
1.3.2 Cephalosporins and cephamycins
Commercial cephalosporins, the most widely used antibiotics today, are all semi-
synthetic derivatives. Unfortunately, fermentation to  obtain  cephalosporins  gives
comparably  low  yields  and  is  expensive.  High-yielding  strains  of  Acremonium
chrysogenum are used in large-scale fermentations to  obtain  cephalosporin  C,  in
this  case  a  big  problem  is  the  chemical  instability  of  the  molecule  leading  to
degradation  during  the  fermentation.  Different  purifications  to  obtain
cephalosporin C are available, which is then converted to 7-aminocephalosporanic
acid (7-ACA) (Figure 1.2), which is used as a starting material for two-thirds of22
the commercial  cephalosporins.    7-ACA  can  be  obtained  by  either  chemical  or
enzymatic deacylation, the  latter is  the  common  method  today  (Elander,  2003)
since  it  is  more  environmentally  friendly  and  cost-effective.  Two  genetically
engineered enzymes are involved: D-amino acid  oxidase (DAO)  converts  the  α-
aminoadipoyl side-chain to glutaryl-7-ACA, and glutaryl acylase (GLA)  removes
the glutaryl side-chain.
 
The  remaining  one-third  of  commercial  cephalosporins  are  derived  from  7-
aminodeacetoxycephalosporanic  acid  (7-ADCA).  Until  recently,  the  preferred
method  to  obtain  7-ADCA  was  chemical  expansion  of  penicillin  G  to
phenylacetyl-7-ADCA followed by enzymatic conversion to 7-ADCA catalysed by
penicillin acylase. A more environmentally friendly procedure has been developed
(Velasco et al., 2000), in which the cefEF gene in  Acremonium  chrysogenum is
replaced  with  the  cefE  gene  of  S.  clavuligerus.  This  produces  high  titres  of
deacetoxycephalosporin  C  (DAOC),  which  is  subsequently  enzymatically
converted to 7-ADCA by D-amino acid oxidase and glutaryl acylase.
Cephamycins are derived in a similar way as cephalosporins but give even lower
fermentation  yields.  There  is  therefore  great  potential  in  further  developing  the
production of cephamycins.
1.3.3 Developments and future possibilities
Traditionally,  β-lactam  production  has  been  improved  by  classical  strain
improvement  techniques,  usually  involving  an  iterative  process  where  the
production strains are exposed to random mutagenesis  followed by  analysis  and
selection  of  superior  production  strains.  Developments  in  molecular  biology
enabled  the  introduction  of  directed  genetic  modifications  through  recombinant
DNA technology, usually referred to as metabolic engineering (Thykaer & Nielsen,
2003).  Different  approaches  are  gene  deletion,  gene  over-expression  or
heterologous expression of new genes and there are many successful examples in
the production of β-lactams.
For example, Penicillium chrysogenum strains have a greater biosynthetic capacity
than  cephalosporin  producing  strains  and  by  moving  the  cefE  gene
(deacetoxycephalosporin  C  synthase)  from  Streptomyces  clavuligerus  to  P.
chrysogenum, adipyl-7-aminodeacetoxycephalosporanic  acid  (adipyl-7-ADCA)  is
produced in the presence of adipic acid (Crawford et  al.,  1995).  From  adipyl-7-
ADCA different cephalosporin derivatives can be obtained. A lot of effort has also
been  invested  in  improving  the  rate-limiting  enzymes  in  the  production  of  β-
lactam  antibiotics.  This  is  dependent  on  the  strain  used  to  synthesize  the
antibiotic,  but  generally  ACVS  has  been  identified  as  the  limiting  enzyme  in
fungi  and  actinomycetes.  By  cloning  the  ACVS  gene  (pcbAB)  or  replacing  its
weak promoter with a strong one, penicillin production in A. nidulans  has  been
shown to increase dramatically (Kennedy & Turner, 1996). Also,  cloning  of  the
expandase/hydroxylase gene (cefEF) in an industrial strain of C. acremonium was
shown  to  increase  cephalosporin  C  production  (Skatrud  et  al.,  1989).  Further23
examples  where  cloning  of  one  or  several  genes  have  improved  the  β-lactam
production  significantly  have  been  reported.  To  obtain  higher  yields  in
fermentations,  further  developments of  this  type  will  be  required  for  industrial
production in the future.
An even more challenging and rewarding task would be to alter the  biosynthetic
enzymes genetically to modify their substrate and product specificity in  order  to
make new variants of  β-lactam  antibiotics  not  possible  today.  Using  enzymatic
methods would also constitute a more environmentally friendly and clean process
compared  with  the  chemical  alterations  that  are  common  today.  Different
approaches  could  be  envisaged.  For  example,  IPNS  could  be  altered  to  accept
modified tripeptides as substrates, and this could lead to new biosynthetic routes
to penems and other bicyclic  β-lactams. Cephalosporins  with  hydrophobic side-
chains would be desirable products. The natural substrate of DAOCS is penicillin
N, that has a polar side-chain and therefore yields cephalosporins with a polar side-
chain. A cephalosporin with  a  hydrophobic side-chain  could  be  readily  purified
compared  with  the  corresponding  compounds  with  polar  side-chains.  By
engineering  DAOCS  to  produce  cephalosporins  of  choice  without  the  need  for
synthetic modifications, production costs and toxic by-products could be reduced.
DAOCS has been shown to have a broad substrate specificity (Lloyd et al., 1999;
Dubus et al., 2001) and enzymatic expansion of substrates with hydrophobic side-
chains has been demonstrated with the wild-type enzyme under certain conditions
(Cho  et  al.,  1998;  Fernandez  et  al.,  1999;  Demain  &  Baez-Vasquez,  2000).
However, a genetic redesign would allow a more efficient conversion and could be
used in industry.
These are just a few examples of enzymes that could potentially be modified, there
are many others possible and different approaches could be taken to obtain new β-
lactam antibiotics. With increasing knowledge about the enzymes involved in the
biosynthesis obtained from a combination of structural, mutagenesis and activity
studies this could become a very powerful tool (Barends et al.,  2004).  Different
approaches are (i) targeted random mutagenesis (ii) site-directed mutagenesis  (iii)
directed evolution, e.g. domain shuffling involving several genes (Crameri et al.,
1998; Arnold, 2001).  24
2. The aim of the thesis
The aim of this thesis is to elucidate the mechanism of action of enzymes in the
biosynthetic  pathways  leading  to  β-lactam  antibiotics.  The  knowledge  of  the
biosynthesis of the β-lactams has increased a great deal during the last years due to
e.g. sequencing of the gene clusters and functional assignment of almost all genes
involved. However, this has led to further important questions that require careful
investigations of the function and mechanism of the biosynthetic enzymes.
We  employ  a  structural  approach  to  study  these  enzymes  using  X-ray
crystallography as the main method. A three-dimensional structure of a protein is a
crucial  ingredient to  obtain  detailed  knowledge  at  the  molecular  level  of  the
protein in question. In addition, to be able to propose mechanisms and elucidate
protein interactions with cofactors and substrates/products, protein structures with
bound ligands are invaluable.
Apart from being important basic research, the knowledge from this study  could
be used to produce new β-lactam antibiotics not available today and also improve
the  existing  production  with  higher  yields  and  more  environmentally  friendly
procedures. Furthermore, an increased chemical knowledge of the  versatile  group
of  non-heme  iron  dioxygenases  is  significant  in  a  broad  scientific  context  and
could be beneficial in both medicine and industry.25
3. Deacetoxycephalosporin C Synthase, DAOCS
(Paper I and II)
3.1 Background
Deacetoxycephalosporin  C  Synthase  (DAOCS)  from  Streptomyces  clavuligerus
catalyzes the oxidative ring-expansion of  the  five-membered  thiazolidine  ring  of
the  penicillin  nucleus  into  the  six-membered  dihydrothiazine  ring  of
cephalosporins  (Figure  3.1).  The  311  amino  acid  long  enzyme  shows  broad
substrate specificity, and can expand  the  thiazolidine  ring  in  various  penicillins
but  at  a  significantly  lower  efficiency  compared  to  the  physiological  substrate
penicillin  N.  DAOCS  belongs  to  the  family  of  2-oxoglutarate  dependent
dioxygenases (2ODDs) which perform a wide range of reactions and require Fe(II),
2-oxoglutarate,  dioxygen    and  usually  a  reducing  agent  for  activity  in  vitro
(Prescott, 1993).
Figure 3.1 The reaction catalyzed by DAOCS.
The structure of DAOCS was the first from this family to be determined (Valegård
et al., 1998) and showed a similar fold as the closely related IPNS (Roach et al.,
1995). The structure is a distorted jelly roll fold with flanking helices,  with  the
active site  buried within  the  central  core  of  the  β-strands  (Figure  3.2).  Several
structures  of  2ODDs  have  since  been  determined  and  although  the  sequence
similarity  in  the  family  is  low,  the  structures  share  a  common  fold.  These
enzymes  all  utilize  a  conserved  2-His-1-carboxylate  facial  triad  that  binds  the
divalent iron (Hegg & Que, 1997).
DAOCS was determined to high resolution  in  complex  with  Fe(II)  and  the  co-
substrate 2-oxoglutarate and a mechanism for the initial steps leading to  a  ferryl
intermediate was suggested (Valegård et al., 1998). However, to reveal details of
the later steps of the reaction leading to cephalosporin formation and to determine
in detail penicillin/cephalosporin interactions with DAOCS  in  order  to  pinpoint
which residues  are  important  for  catalysis  and  binding,  further  complexes  were
crucial.  Such  knowledge  would  be  invaluable  for  future  genetic  redesign  of
DAOCS to accept and expand a wider range of penicillins not possible today, e.g.
hydrophobic penicillins. Furthermore, at the start of this project, few details were
known about the important group of 2ODDs and DAOCS was the only structure
available at that time. To understand how these versatile enzymes use the highly
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reactive iron in catalysis is of general importance and in particular we wanted  to
understand how the high oxidation-state ferryl intermediate is formed.
A                                                         B
Figure 3.2 The crystal  structure  of DAOCS. (A) The monomer in complex  with  Fe(II),
shown as a sphere. (B) The crystallographic  trimer of DAOCS in  the  R3  crystal  form
viewed down the 3-fold axis. The positions of the N and C termini are indicated.
3.1.1 The need for a new crystal form of DAOCS
The structure of DAOCS was solved using crystals belonging to space group R3
(Valegård et al., 1998). The packing of the  individual  molecules in  this  crystal
form was identified as a possible complicating factor for obtaining complexes of
DAOCS. In these crystals, residues 308-311 (the carboxy-terminal arm) of the apo
enzyme participate in an intermolecular contact. The arm binds in the active site of
a neighbouring molecule in a cyclic fashion, forming tight  trimers  (Figure  3.2).
Dynamic  laser  light  scattering  on  the  apo  enzyme  in  solution  revealed  an
equilibrium between monomers and trimers, however in the presence of iron and
2-oxoglutarate the equilibrium was shifted towards the monomeric form (Lloyd et
al.,  1999).  This  implies  that  it  is  the  monomeric  form  of  DAOCS  that  is
catalytically  active.  It  was  therefore  believed  that  the  C-terminal  arm  could
interfere with penicillin/cephalosporin binding.
A second complication is merohedral twinning in the R3 crystal form (Terwisscha
van Scheltinga et al., 2001). Merohedral twinning is a packing anomaly in which
the distinct domains in the crystal superimpose completely in  three  dimensions.
The twinning complicated  the  structural  determination of  DAOCS.  It  is  also  a
complicating factor in the study of ligand complexes of DAOCS since detwinning
the data  amplifies  experimental  errors.  The errors  increase  with  increasing  twin
fraction and become infinite in a perfect twin. The twin fraction of the DAOCS R3
crystals varies  from  almost  zero  to  almost  perfect  twinning  (0.5).  Merohedral
twinning can only be detected by collecting and scaling a few degrees of data (10-27
15°), therefore many crystals need to be prepared and screened to find crystals with
acceptable twin fractions. In practice this means that to obtain reliable atomic data,
only crystals with a twin fraction less than 0.3 are acceptable.
For  these reasons  a  different  crystal  form  of  DAOCS  was  needed.  Extensive
crystallisation screening of  native  DAOCS  was  performed  without  any  success.
Therefore,  modifications  of  DAOCS  to  break  the  trimer  formation  and  abolish
twinning were considered. An obvious approach is truncation of the C terminus.
However, the C-terminus  has  been  implicated  to  play  an  important  role in  the
function of DAOCS and mutations and  truncations  of  the  C-terminus  had  been
shown to yield kinetically altered or even inactive DAOCS (Lee et al., 2001; Chin
& Sim, 2002; Lee et al., 2002). Alterations in this region were therefore avoided.
Instead, a N-terminal 6x-histidine tag  was  added  to  DAOCS  and  a  new  crystal
form  was  obtained.  This  crystal  form  will  now  be  presented  in  some  detail
followed by  a  presentation  of  the  complexes  obtained  by  working  with  both
crystal forms in parallel.  
3.2 His-tagged DAOCS (Paper II)
3.2.1 Expression, purification and oligomeric state
The gene  for  DAOCS  was  re-cloned  with  an  N-terminal  6x-histidine  tag  into
vector  pET-15b  and  over-expressed  in  E.  coli.  The  His-tagged  protein  was
separated on a nickel affinity column and further purified by gel-filtration. The tag
greatly simplified the purification of  DAOCS  compared  to  previously  described
procedures  (Lloyd  et  al.,  1999).  Mononuclear  ferrous  enzymes  are  oxygen-
sensitive and degrade under  aerobic  conditions  (Barlow et  al.,  1997).  With  the
new  construct,  the  time  for  purification  was  considerably  shortened,  which
minimised exposure to oxygen and resulted in less degradation of the protein.
Using gel-filtration analysis and dynamic laser light-scattering measurements, His-
tagged apo-DAOCS was shown to be monomeric in solution.  In  sharp  contrast,
the  native  apo-DAOCS  exists  as  an  equilibrium  mixture  of  monomeric  and
trimeric forms in solution (Lloyd et al., 1999).
3.2.2 Activity meassurements
A spectrophotometric assay has been developed by Dubus et al. (2001) to measure
the  activity  of  DAOCS.  The assay  is  based  on  the  continuous  monitoring  of
absorbance  at  260  nm  due  to  the  production  of  the  deacetoxycephem  ring.  To
measure absorbance at 260 nm involves a high background absorbance, caused by
the assay ingredients. For instance, a  high  concentration  of  ascorbate  (100  µM)
that absorbs strongly at this wavelength is necessary. In the measurements on His-
tagged DAOCS presented next, the concentration of penicillin had to be relatively28
high due to a high Km. This caused an even higher absorbance background and a
0.2 cm cuvette had to be used to measure the absorbance satisfactorily.
The assay was used to investigate if His-tagged DAOCS was active. The substrate
used was penicillin G since the natural substrate penicillin N, is very  labile  and
not  commercially  available. The result  shows  that  DAOCS  is  active  and  can
expand penicillin G to the corresponding cephem with an apparent Km of 20.6 mM
and  a  kcat  of  0.056  s
-1  (Paper  II).  The  Km  value  is  significantly  increased  in
comparison to native DAOCS for which a value of 0.89 mM has  been  obtained
(Dubus et al., 2001). However, the kcat  value is in a similar range as the kcat for
native DAOCS: 0.079 s
-1. These results indicate that the His-tag affects substrate
binding but not the rate of the  turnover.  Judged  by  inspection  of  the  structure,
where the N-terminus is located on the surface far away from the active site in both
crystal forms, the effect of the  His-tag  on  the  kinetic  properties  is  likely  to  be
indirect.
3.2.3 Crystallisation
Crystals  of  His-tagged  DAOCS  were  obtained  after  extensive  screening  in
conditions modified  to  those  used  to  obtain  native  DAOCS  crystals.  The new
crystals were obtained by lowering the ammonium sulphate concentration and by
reducing the crystallisation temperature from 20° C to 4° C. Further, no addition
of 2-oxoglutarate was necessary to obtain crystals as was the case with the native
protein. In addition, the crystals of His-tagged protein grew spontaneously without
streak  seeding,  which  was  crucial  to  obtain  native  crystals.  Another  important
factor  was  to  slow  down  the  rate  of  vapour  diffusion  by  the  use  of  Al’s  oil
(Hampton Research) layered over the reservoir solution, to avoid the formation of
microcrystals.  The  crystals  are  shaped  like  hexagonal  rods  instead  of  the
rhombohedrally shaped native crystals (Figure 3.3).
A                                                        B
Figure 3.3 Different crystal  forms of apo-DAOCS. (A) Native, space group  R3 (crystal
form I). (A) His-tagged, space group P3121 (crystal form II).29
3.2.4 The apo-structure of His-tagged DAOCS
The crystals of  His-tagged  DAOCS  belong  to  space  group  P3121  and  are  not
twinned judged by  their  standard  probability  distribution  of  intensities  (CCP4,
1994). The structure was solved  by  molecular  replacement  with  the  native  apo-
DAOCS as a search model. From now on, for simplicity, the R3 crystals will be
named crystal form I, and the P3121 crystals, crystal form II.
The packing of molecules in the two crystal forms differ considerably. In crystal
form II, the trimer formation is broken and the C-terminus is not engaged in inter-
molecular contacts (Figure 3.4),  instead  the  last  12  residues  are  disordered.  By
inspection of the crystal packing it is easy to envisage why a modification at the N
terminus  would  affect  the  interaction  with  the  C  terminus.  In  form  I  crystals
(Figure 3.2), the N terminus is locked on the surface of the molecule  and  packs
against two adjacent molecules of DAOCS (one within the same trimer, the other
with a neighbouring trimer). Additional residues attached to the N terminus would
disrupt  these interactions  and  interrupt  the  trimer  formation.  This  is  what  we
observe with the His-tagged protein; in crystal form II both the N- and C-terminal
tails are at the surface of  the  molecule,  and  not  involved  in  any  intermolecular
contacts.   
The packing of molecules in form II crystals is loose with big channels of solvent
(Figure 3.4). Hence, the solvent content of crystal form II is much higher than in
crystal form I: ~70% compared to ~40%. This allows substantial flexibility in the
lattice and results in high Wilson B factor of the protein (62 Å
2). The high solvent
content and loose packing result in fragile crystals that are difficult to handle and
could also explain the difference in diffraction quality compared to crystal form I
(2.3 Å compared to 1.3 Å).
A   B
Figure 3.4 Packing of DAOCS in form II crystals.  (A) Crystal  form II viewed down the
3-fold screw axis. (B) Zoom-out to show the large solvent channels.30
As expected, the overall folds of His-tagged and native DAOCS are very similar,
(Figure 3.5). A superposition of the Cα atoms with a cut-off of  3.8  Å  gave  an
r.m.s deviation of 1.1 Å for the two structures, with 20 residues not included in
the superposition as they lie outside the cut-off limit.  Most of these residues are
found in the C-terminal region where the most significant differences between the
two  structures  are  observed.  Analysis  of  the  two  structures  with  the  program
DYNDOM (Hayward & Berendsen, 1998) indicated the presence of two domains,
comprising residue 1-267 and 268-299, respectively, where the C-terminal domain
in crystal form II is rotated 16° towards the active site on a hinge  consisting  of
Pro267 and Asn268. As mentioned above, the C-terminal arm (residue 308-311) is
no longer fixed in the active site of  the  neighbouring  molecule  and  there  is  no
electron density for the last 12 residues of crystal form II,  which  have  not  been
modelled.
Figure 3.5 Stereographic superposition of the Cα traces of crystal form I (dark grey)
and II (light grey) of DAOCS with the active site iron indicated as a sphere. The hinge
residue (268) and the N- and C termini are indicated.
3.3 Ligand complexes with DAOCS
To  obtain  penicillin  and  cephalosporin  complexes  in  crystals  of  DAOCS  was
recognised  not  to  be  a  straightforward  task  due  to  a  number of  reasons.  First
oxygen is a substrate, therefore all complexes had to be prepared and frozen in an
anaerobic box to avoid reaction and/or oxidation of the divalent iron. Furthermore,
both DAOCS and the penicillin/cephalosporin molecules are sensitive and  easily
degrade or hydrolyse. The natural substrate, penicillin N,  is  very  labile  and  not
commercially available. DAOCS  has  been  shown  to  expand  a  number of  other
penicillins but with a significantly higher Km (Lloyd et al., 1999),  leading  to  a
requirement for high soaking concentrations of these compounds. Like  penicillin
N, these penicillins are  labile  and  easily  hydrolysed.  To  dissolve  and  keep  the
penicillins/cephalosporins  soluble  at  the  required  concentrations  in  the  extreme
conditions  of  high  concentrations  of  iron  and  ammonium  sulphate  was  not
straightforward and was not possible for all substrates.31
3.3.1 Complex with DAOCS-Fe(II)
Electron density maps obtained from P3121 crystals of  His-tagged  DAOCS  into
which  Fe(II)  had  been  soaked  featured  strong  density  at  the  iron-binding  site
(Paper  II).  Moreover,  some  unexpected  density  was  found  at  the  iron  trans  to
His243. This density was  successfully  modelled  as  ethylene  glycol,  which  was
used as cryo-protectant. One further ethylene glycol molecule was also found and
modelled in the active site (Figure 3.6). The ordered binding of cryo-protectants in
proteins is commonly observed (Garman & Schneider,  1997)  and  has  also  been
observed  for  glycerol  in  crystal  form  I  of  DAOCS.  For  this  reason,  no  cryo-
protectant was used  in  further  work  with  ligand  complexes.  The penicillin  and
cephalosporin molecules seem to partly function as cryo-protectants, since freezing
of apo DAOCS without any cryo-protectant results in non-diffracting crystals. The
binding of ethylene glycol and glycerol in the active site points to the capacity of
DAOCS to bind small organic molecules containing carboxyl and carbonyl groups
in the active site.
Figure 3.6 Stereoview of the active site of His-tagged DAOCS-Fe(II) at 2.5 Å resolution.
The structure was obtained by soaking crystals in 20 mM Fe(NH4)2(SO4)2 followed  by a
quick soak in 30% ethylene glycol before flash freezing in liquid nitrogen.  The 2mFobs-
DFcalc electron  density  map  is  contoured  at  1.0  σ  where  σ  is  the  root  mean  square
electron density for the unit cell.
3.3.2 Complex with DAOCS-Fe(II)-2-oxoglutarate
The structure solution of other 2ODDs has revealed two different binding modes
of the co-substrate 2-oxoglutarate to the iron. One is represented by DAOCS and
is also observed in anthocyanidin synthase, ANS  (Wilmouth  et  al.,  2002).  The
other binding mode is represented by CAS (Zhang et al., 2000) and is also found
in TauD (Elkins  et  al.,  2002b),  alkylsulfatase,  AtsK  (Muller et  al.,  2004)  and
factor  inhibiting  hypoxia-inducible  factor,  FIH  (Elkins  et  al.,  2003).  2-
Oxoglutarate  binding  has  also  been  reported  in  carbapenem  synthase,  CarC,
(Clifton et al., 2003) but  here  2-oxoglutarate  binds  in  an  intermediate  position
between  the  binding  sites  in  DAOCS  and  CAS,  but  closer  to  the  DAOCS
binding.  The  relative  positions  of  the  1-carboxylate  of  2-oxoglutarate  and  a
ligating water are transposed in the structures of CAS and DAOCS (Figure 3.7),
and hence the proposed position of the ferryl will vary in the structures.32
A                                                          B
Figure 3.7 Comparison  of the iron  coordination  of  (A)  DAOCS-Fe(II)-2-oxoglutarate
and (B) CAS-Fe(II)-2-oxoglutarate.
For this reason we wanted to investigate the  2-oxoglutarate  binding  to  DAOCS
also in the P3121 crystal form. This turned out not to be easy. Due to the presence
of ethylene glycol in the active site in the DAOCS-Fe(II) structure the use of cryo-
protectants  that  could  bind  in  the  active  site  was  avoided.  Data  from  crystals
treated in  different  ways  was  collected:  (i)  without  cryo-protectant,  (ii)  with  2-
oxoglutarate as a ‘cryo-protectant’ at very high concentrations (1 M) and (iii) with
oils as cryo-protectant. The data are not good in any of the cases. There  are  ice-
rings that result in low completeness in some resolution shells, and the crystals do
not diffract well enough to reveal details (~3.1-3.2 Å). However, inspection of the
active site shows weak density at the corresponding 2-oxoglutarate binding site in
crystal form I of DAOCS, but the structures were not possible to refine since the
observation/parameter ratio was too low.
3.3.3 Complex with DAOCS-Fe(II)-succinate
A complex of DAOCS ligated by iron and the co-product succinate was obtained
using the R3 crystal form (Paper I). Succinate ligates the iron in  a  monodentate
manner at the position expected if it were produced by oxidative decarboxylation
of  the  bound  2-oxoglutarate,  following  the  previously  published  mechanism
(Valegård et  al.,  1998).  Like  2-oxoglutarate,  succinate  forms  a  salt  bridge  to
Arg258.  The observed  binding  of  succinate  further  supports  the  2-oxoglutarate
binding and the mechanistic proposal for the first half of the reaction (Valegård et
al., 1998).
3.3.4 Complex with DAOCS-Fe(II)-penicillin
Soaking  form  II  crystals of  DAOCS  with  iron,  2-oxoglutarate  and  ampicillin
produced weak density at the iron that could be modelled and refined as ampicillin
(Figure 3.8) (Paper II). There was no density for  2-oxoglutarate.  The resolution,
2.7  Å,  limits  the  details  that  can  be  interpreted  from  the  structure.  Penicillin
complexes  with  crystal  form  I  (Paper  I)  have  been  obtained  under  similar
conditions, but to a significantly higher resolution: 1.5 and 1.7 Å.  With  crystal
form I, a mixture of penicillin and 2-oxoglutarate were found to bind. The binding
sites of the penicillins clearly overlap in the two crystal  forms  (Figure  3.8).  To
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obtain  productive  penicillin  complexes  of  DAOCS  it  was  crucial  to  soak  the
crystals  in  a  combination  of  penicillin  and  2-oxoglutarate  or  penicillin  and
succinate. Without the presence of the co-substrate  or  co-product  a  different  and
presumably unproductive binding mode of the penicillin  molecule  was  observed
(Paper I) (Figure 3.8).
In the productive binding in both crystal forms, penicillin directly ligates the iron
with the sulphur atom of the thiazolidine ring trans to His243. This positions the
β-methyl group to be  inserted  into  the  penicillin  ring  during  catalysis  in  close
proximity of the proposed ferryl position. This is in contrast to the unproductive
penicillin binding where the C3 carboxylate  on  the  thiazolidine  ring  ligates  the
iron and hence the β-methyl group  is  far  away  from  the  ferryl  position  (Figure
3.8), too far away for this binding to be productive. In the productive complexes,
the penicillin side chains are in close vicinity to  Arg160  and  Arg162  that  from
mutational studies have been shown to be crucial for activity and proposed to bind
the  substrate  (Chin  et  al.,  2001;  Lipscomb  et  al.,  2002).  In  addition,  the
productive penicillin is bound in the same orientation as the penicillin substrate in
the closely related IPNS (Burzlaff et al., 1999) (Figure 3.8).
In both crystal forms of DAOCS, the binding site for penicillin in the productive
complexes was shown to overlap with 2-oxoglutarate or  succinate  binding.  This
has mechanistic implications for  catalysis  by  DAOCS,  precluding  simultaneous
binding  of  penicillin  and  2-oxoglutarate  or  succinate,  which  will  be  discussed
below.
Even if the topological organisation of the penicillin  ligands  around  the  iron  is
found to be similar in the two crystal forms, there are also some clear differences
observed (Figure 3.8). These are mainly caused by differences in crystal packing.
The position  of  the  penicillin  side  chain  in  crystal  form  II  clashes  with  the
position of residues 304-306 of the  C-terminal  arm in  the  form  I  crystals.  The
penicillin in crystal form I has to assume a different orientation and move towards
Arg160, which results  in  the  disorder  of  this  residue.  The penicillin  in  crystal
form II interacts with both Arg160 and Arg162. The difference is also seen at the
orientation of the penicillin nucleus, which in crystal form II is rotated  by  ~70°
relative to its position in the form I crystals.
Figure 3.8 (A) Stereoview of the active site  of His-tagged  DAOCS-Fe(II)-ampicillin at
2.7  Å  resolution.  The  structure  was  obtained  by  soaking  crystals  in  20  mM
Fe(NH4)2(SO4)2,  33  mM  2-oxoglutarate  and  88  mM  ampicillin.  The  2mFobs-DFcalc
electron  density  map is contoured  at 1.0 σ where σ is  the  root  mean  square  electron
density  for  the  unit  cell.  (B)  Productive  penicillin  binding  in  crystal  form  II.  (C)
Penicillin  binding  in  IPNS,  pdb-id  1QJE.  (D)  Unproductive  penicillin  binding  in
crystal form I. (E) Superposition of the active sites in Form II DAOCS-Fe(II)-ampicillin
(coloured  orange,  ampicillin  coloured  yellow)  and  Form  I  DAOCS-Fe(II)-ampicillin
(coloured light blue, ampicillin coloured dark blue).  34
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Figure 3.8 (A)-(E) Legend on previous page.35
3.3.5 Complex of DAOCS-Fe(II)-cephalosporin
Soaking  of  crystal  form  II  with  iron  and  the  natural  product
deacetoxycephalosporin  C  produced  weakly  diffracting  crystals  and  diffraction
images with ice-rings. This was probably due  to  the  absence  of  cryo-protectant.
Extensive screening was performed and eventually a suitable crystal was found that
yielded  a  data  set  to  3.0  Å.  Weak  density  around  the  iron  was  modelled  and
refined as DAOC  (Figure  3.9)  (Paper  II).  Soaking  of  crystal  form  I  with  iron,
succinate and deacetoxycephalosporin C produed a DAOCS-Fe(II)-DAOC complex
to 1.7 Å (Paper I). There is no density for succinate.
In both crystal forms, the cephalosporin molecules bind in the same orientation as
the productively bound penicillins and partly overlap with each other (Figure 3.9).
DAOC in both structures is shown to overlap with 2-oxoglutarate and succinate.
In  the  form  I  structure,  the  sulphur  atom  of  the  dihydrothiazine  ring  directly
ligates  to  the  iron  whereas  in  the  form  II  structure  the  dihydrothiazine  ring  is
further away from the iron and the methyl group of the dihydrothiazine ring points
toward the iron.
Like  the  penicillin  molecules,  the  cephalosporin  molecules  in  the  two  crystal
forms take up slightly different orientations (Figure 3.9), with the  cephalosporin
molecule  of  crystal  form  II  positioned  further  away  from  the  iron.  The
cephalosporin binding site of crystal form II does not overlap with the position of
the C-terminus of the same molecule from crystal form I, but comes very close to
the position of the C-terminus of yet another molecule within the trimer of crystal
form I. The differences in cephalosporin binding observed between the two crystal
forms are similar to the differences in penicillin binding and are probably an effect
of the crystal packing.
Figure 3.9 (A) Stereoview of the active site of his-tagged  DAOCS-Fe(II)-DAOC at 3.0 Å
resolution.  The structure  was obtained  by soaking  crystals  in 20 mM  Fe(NH4)2(SO4)2,
and  150  mM  deacetoxycephalosporin  C.  The  2mFobs-DFcalc electron  density  map  is
contoured at 0.9σ where σ is the root mean square electron density for the unit  cell. (B)
Superposition  of  the  active  sites  in  form  II  DAOCS-Fe(II)-DAOC  (coloured  orange,
DAOC coloured  yellow) and form I DAOCS-Fe(II)-DAOC (coloured  light  blue,  DAOC
coloured dark blue, C-terminus from symmetry-related molecule coloured cyan).36
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Figure 3.9 (A)-(B) Legend on previous page.
3.4 The active site and the role of the C terminus
Substantial  differences  in  the  C  terminal  domain  of  DAOCS  were  observed
between the two crystal forms, starting at the hinge between residues 267 and 268.
The differences suggest that  the  C-terminal  domain  is  flexible and  can  take  up
different conformations.
Further  differences  between  the  two  crystal  forms  were  observed  upon  binding
penicillin  and  cephalosporin  molecules  in  the  active  site.  The  differences  are
caused by the crystal packing where  the  C  terminus  in  crystal  form  I  interferes
with penicillin and cephalosporin binding. Therefore one can speculate that crystal
form II probably more reflects the active enzyme in solution, since no adjustments
due  to  the  presence  of  the  C  terminus  are  necessary  when  binding
substrate/product.
Inspection of the binding of penicillin and cephalosporin reveal  surprisingly  few
interactions  of  DAOCS  to  the  side-chains  of  the  penicillin/cephalosporin
molecules,  except  from  Arg160  and  Arg162.  Site-directed  mutagenesis  studies
combined with activity assays have demonstrated the importance of the C-terminal37
arm for activity, where some mutations even were shown to increase the activity
for hydrophobic penicillins (Chin et al., 2001; Chin & Sim,  2002). Residues can
be added without loss of activity but the successive shortening of the C-terminal
arm diminishes catalytic activity (Lee et al., 2001). The C terminus has also been
shown to be important in the closely related enzymes IPNS (Sami et  al.,  1997)
and DAOC/DACS (Lloyd et al., 2004).
Based on the  lack  of  direct  interaction  of  the  penicillin/cephalosporin molecule
with  amino  acids of  the  enzyme  and  the  well-established  importance  of  the  C
terminus, it seems reasonable that the C terminus of DAOCS plays an important
role in binding and orienting the substrate. In  crystal  form  I  the  C  terminus  is
locked in the tight trimer interactions but why any interaction of the C terminus is
not seen in crystal form II one can only speculate. It is possible that for  this  to
occur substantial rearrangements are necessary  of  the  whole  C  terminal  domain,
starting at the  hinge  at  residue  268.  Due  to  crystal  packing  this  might  not  be
possible in crystal form II, even if the packing is relatively loose in  the  crystal.
Unsuccessful attempts have been made to co-crystallise DAOCS in the presence of
penicillin.
   
Regarding  the  function  of  the  trimers,  one  can  speculate  that  DAOCS  in  the
unactive apo-form protects the flexible C terminus from proteolytic degradation by
forming  tight  trimers.  In  the  presence  of  iron  and  2-oxoglutarate  the  trimer
dissociates and the C terminus guides and binds the penicillin substrate.
It is not directly obvious from the structures which residues should be altered or
the nature of the change to obtain a more efficient DAOCS and/or a DAOCS with
altered  substrate specificity.  The interactions  from  Arg160  and  Arg162  to  the
penicillin/cephalosporin involve the ring-core structure or  the  carbonyl  group  on
the side chain of the penicillin/cephalosporin. These interactions are also important
for  hydrophobic penicillins  and  therefore  should  not  be  modified  in  order  to
modify the side-chain preference of DAOCS. There are no direct interactions from
DAOCS with the tail of the side-chain of the penicillins, it is likely that  the  C
terminus will interact with this part. Therefore the C terminus of DAOCS may be
a prime target for mutagenesis, which has already been shown in several examples
(Lee et al., 2001; Wei et al., 2003; Chin et al., 2004). Furthermore, the substrate
binding pocket  of  DAOCS  seems  relatively  wide  and  flexible which  might  be
advantageous since it could be fairly easy to alter the substrate specificity. In fact,
in Paper II speculations that DAOCS might be capable of other catalytic activities
are made.38
3.5 The mechanism of DAOCS
All the crystal complexes obtained with DAOCS indicate that the binding of the
co-substrate/substrate  and  co-product/product  in  the  active  site  overlap  and  that
these molecules therefore  cannot  bind  at  the  same time.  This  has  mechanistic
implications for catalysis by DAOCS.
Substrate interference of this type should affect the kinetic behaviour of DAOCS
in solution. Indeed this was shown using steady-state rate measurements of native
DAOCS where one substrate concentration was varied while the  other was  fixed
(Paper  I).  The results  show  a  major  decrease  in  the  steady-state  rates  at  fixed
penicillin  concentrations  (using  both  penicillin  G  and  ampicillin)  at  increasing
concentrations of 2-oxogutarate. The same behaviour was also observed at fixed 2-
oxoglutarate concentrations with increasing concentrations of penicillin, albeit to a
less extent.  This behaviour is expected when two ligands compete for the  same
binding  site  on  the  enzyme  and  is  in  support  of  our  structural  results.  A
commonly  observed  feature  in  many  2-oxoglutarate  dioxygenases  including
DAOCS is uncoupled turnover, where 2-oxoglutarate is converted to succinate and
carbon  dioxide  without  concomitant  oxidation  of  ‘prime’  substrate (Prescott &
Lloyd,  2000).  The  rate  of  uncoupled  turnover  increases  with  increasing
concentration of 2-oxoglutarate, consistent with our steady-state results.
The difference  observed  in  penicillin  binding  in  the  absence  or  presence  of  2-
oxoglutarate or succinate suggests that the active site is incomplete for productive
binding  without  the  co-substrate  or  co-product.  The  incoming  penicillin  must
encounter  an  active  site  with  altered  geometry  and  charge  state  when  the  co-
substrate or co-product is present and may bind differently than in the unliganded
enzyme.
From  our  structures  of  DAOCS  a  mechanism for  cephalosporin  formation  was
proposed  (Figure  3.10).  The  reaction  sequence  starts  with  binding  of  2-
oxoglutarate, which activates the iron for  oxygen  binding.  With  bound  oxygen,
oxidative decarboxylation of 2-oxoglutarate occurs and results in the formation of
an  oxidizing  intermediate  plus  succinate  and  carbon  dioxide  as  by-products.
Carbon  dioxide  is  a  weak  ligand  to  the  iron  and  is  likely  to  leave,  whereas
succinate  remains  bound  and  stabilizes  the  oxidizing  iron  species.  Quantum
molecular  dynamic  calculations  of  different  iron-oxygen  adducts  by  Graziella
Ranghino identified the planar peroxo as more stable than the ferryl species (Paper
I). The oxidizing iron species may thus be stored transiently in the peroxo  form
within the protein to await a reaction with the penicillin substrate. When penicillin
expels succinate, it triggers oxidative attack on  itself.  The binding  of  penicillin
brings the β-methyl group of the  penicillin  core  within  reacting  distance  of  the
expected ferryl oxygen. Ring expansion, involving radical formation and  transfer
of two electrons and two protons to the oxygen, results in  the  formation  of  the
cephalosporin product and water.39
Figure 3.10 Proposed mechanism for the ring expansion catalysed by DAOCS based on
the  mode  of  penicillin  and  cephalosporin  binding  in  the  crystal  structures.  The
presumed oxidation states of the iron are marked.
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3.6 Comparison of DAOCS to other 2ODDs
The overlapping binding of substrate and co-substrate in  DAOCS  proposed  here
differs  to  other  2-oxoglutarate  dependent  dioxygenases  where  structural
information on substrate and co-substrate binding is available. In CAS (Zhang et
al.,  2000),  TauD  (Elkins  et  al.,  2002b),  AtsK  (Muller  et  al.,  2004),  ANS
(Wilmouth  et  al.,  2002),  FIH  (Elkins  et  al.,  2003)  and  CarC  (Clifton  et  al.,
2003), 2-oxoglutarate and substrate bind at different positions simultaneously.
Furthermore,  the  proposed  mechanism  for  DAOCS  differs  from  the  generally
proposed mechanism of 2ODDs, reviewed in Schofield & Zhang, 1999. It is based
on kinetic data (Holme, 1975; Kivirikko & Pihlajaniemi, 1998) that  indicate  an
ordered sequential mechanism, with the binding of 2-oxoglutarate followed by that
of the prime substrate and last dioxygen. Product release occurs in order:  carbon
dioxide  followed  by  succinate  or  prime  product,  depending  on  their  relative
concentrations. This  mechanism is  supported  by  the  structures  of  2ODDs  with
non-overlapping substrate and co-substrate binding. Spectroscopic studies of CAS
(Zhou et al., 2001) and TauD (Price et al., 2003) indicate  that  only  when  both
substrate and  co-substrate  are  present  is  the  ferrous  site  converted  into  a  five-
coordinated species with enhanced reactivity  toward  dioxygen.  Based  on  this,  a
mechanism was  proposed  where  the  binding  of  the  main  substrate  triggers  a
rearrangement  to  a  five-coordinated  species  that  will  bind  oxygen,  leading  to
oxidation of the substrate.
The position of the substrate in DAOCS also differs  compared  to  other 2ODDs
(CAS, CarC, ANS, AtsK, HIF and TauD). In DAOCS, the penicillin substrate is
found  to  directly  ligate  the  iron  whereas  in  other  2ODDs,  the  substrate  is
positioned at a distance of more than 4 Å from the iron, albeit at the same side of
the  iron  as  in  DAOCS.  Since  2-oxoglutarate  binding  in  CAS  and  others  are
different compared to DAOCS (Figure 3.7), the ferryl was proposed to bind trans
to the position corresponding to His243 in DAOCS. In this case, the ferryl would
be  perfectly  positioned  to  react  with  the  bound  substrates  in  these  enzymes.
However,  an  intriguing  observation  with  CAS  indicates  that  oxygen  may  be
bound  in  several  modes  and  limits  the  certainty  the  ferryl  and  2-oxoglutarate
positions in these enzymes can be  determined.  Upon  exposure  of  CAS-Fe(II)-2-
oxoglutarate-deoxyguanidinoproclavaminate crystals to nitric oxide (NO, dioxygen
analogue), NO was found not to bind at the  expected  position  but  trans  to  the
position corresponding to His183 in DAOCS. This could be interpreted that NO
binding causes a rearrangement around the  iron  resulting  in  2-oxoglutarate  iron-
ligation similar to DAOCS (Zhang et al., 2002). If NO correctly mimics  bound
dioxygen in CAS, the ferryl would be incorrectly oriented to react with the bound
substrate and the catalysis would have to involve a rearrangement to flip the ferryl
to the correct position after CO2 release. It is of course possible that the observed
NO binding does not  correspond  to  the  correct  dioxygen  binding  in  CAS,  but
without further evidence this observation has to be taken into account to show that
the mechanism of other 2ODDs is not completely elucidated.41
As described, DAOCS seems to differ from other 2ODDs investigated so far in a
number of  ways.  In  fact,  DAOCS  seems  to  resemble  IPNS  more closely.  The
amino acid sequences of DAOCS and  IPNS  are  significantly  more homologous
compared to DAOCS and other 2ODDs, excluding the closely related DACS and
DAOCS/DACS. The high homology is also revealed in structural terms. A DALI
search  (Holm  &  Sander,  1993)  of  the  DAOCS  structure  revealed  IPNS  as  the
clearly most similar structure, Table 3.1. Furthermore,  the  penicillin  binding  in
IPNS and DAOCS is very similar, with the sulphur atoms ligating the iron at the
same position and the same orientation of the penicillin side-chains (Figure 3.8).
However, DAOCS and IPNS share their fold with other 2ODDs, which implies a
divergent  evolutionary relationship.  Since  the  genes  for  DAOCS,  DACS  and
IPNS are all positioned in the same gene cluster one can imagine that they have
evolved from the same ancestor  and,  following  gene  duplication  have  taken  up
different functions.
Table 3.1 DALI search results for structures similar to DAOCS
PDB ID Z-Score r.m.s.d RA %SI Description
1BK0 22.7 2.6 245 21 IPNS
1GP4 19.4 3.2 241 20 ANS
1E5R 7.1 3.9 143 13 Proline  3-hydroxylase
1DRT 6.3 3.9 148 9 CAS
1GQW 6.0 4.0 137 8 TauD
1NX4 5.4 3.2 123 10 CarC
PDB, Protein  Data Bank; r.m.s.d, root-mean-square  deviation;  RA, number of residues
aligned; &SI, percent sequence identity over the aligned fragments.
From  this  reasoning  it  may  appear  that  DAOCS  is  an  exception  to  the  other
2ODDs. However, still very few enzymes in the diverse  family  of  2ODDs  have
been thoroughly investigated and it is very likely that also other 2ODDs function
in a similar way as DAOCS. The differences point to the diversity of the family.
Further  studies  on  members  in  the  family  of  2ODDs  using  a  combination  of
methods are necessary to yield more knowledge about these enzymes. In particular,
knowledge about the  high  oxidation-state  intermediates  is  crucial  to  understand
their mechanism more completely.   42
4. ORF7 in the clavulanic acid biosynthesis
4.1 Background
The biosynthetic route of clavulanic acid in S. clavuligerus, presented in  section
1.2.3,  is  not  fully  characterised.  In  particular,  some  of  the  late  steps  are  yet
uncharacterised. The identified gene cluster contains at least 18 genes and many of
the identified open reading frames  (ORFs)  have  not  had  a  function  assigned  to
them yet.
One  of  these genes  is  orf7,  which  was  shown  to  be  vital  for  clavulanic  acid
biosynthesis using a gene disruption mutation approach (Jensen et al., 2000). The
protein encoded by the orf7 gene, ORF7, has an estimated molecular weight of 61
kDa.  Sequence  comparison  using  BLAST  identified  it  to  be  most  similar  to
bacterial  oligopeptide-binding  proteins.  ORF7  has  therefore  been  suggested  to
bind  and/or  transport  clavulanic  acid  and/or  precursors.  Another  gene,  orf15
encoding a putative oligopeptide-binding protein, ORF15,  was  identified  further
down in the clavulanic acid gene cluster, with 48% amino acid sequence similarity
to  ORF7.  Both  genes  are  required  for  clavulanic  acid  production  and  cannot
replace  each  other (Lorenzana et  al.,  2004).  However,  clavam  intermediates  are
formed in the orf15-disrupted mutant cells.
4.2 Expression and purification of ORF7
ORF7 from S. clavuligerus was cloned to the pET-24a vector by collaborators in
Oxford and sent to Uppsala. The plasmid was transformed into E. coli BL21 DE3
cells and the expression gave high yield of soluble protein.
The initial  purification  of  ORF7  outlined  in  Oxford  was  further  developed  in
Uppsala. ORF7 is expressed in native  form  and  the  purification  involves  many
steps, but the whole procedure can be performed within 30 hours. The first  step
involves an ion-exchange column with Q-Sepharose fast flow media followed by a
hydrophobic interaction purification step. This is followed by gelfiltration using a
Superdex200 column and another ion-exchange column, MonoQ, as the last step.
The protein appears reasonably pure already after the hydrophobic interaction step
and very little improvement in the purity is achieved in the following steps of the
purification.  ORF7  separates  from  gel  filtration  and  MonoQ  columns  in  sharp
peaks  without  apparent  overlap  from  other proteins.  Nevertheless,  SDS  PAGE
(Figure  4.1)  and  native  gel  analysis  shows  the  protein  is  not  pure.  There  are
several major low molecular weight contaminant bands present, in addition to the
61 kDa band of ORF7. Speculations  to  the  identity  of  these bands  led  to  two
main  theories.  One  possibility  is  break-down  products  of  ORF7.  Proteolytic
degradation and break-down of sensitive proteins during purification is a common
problem in protein purification. In the purification of ORF7, normal  precautions
to avoid this have been taken: a tablet of a cocktail of protease inhibitors is added
to  the  cells  during  the  cell  disruption  and  EDTA  is  present  during  the  whole43
purification. All  purification  steps  are  performed  at  4°C  and  without  delays in
between. The other possible explanation for the impurities relates to the putative
function of ORF7, as a homologue to oligopeptide-binding proteins. It is possible
that ORF7 could bind different peptides/proteins present in the E. coli cells during
the expression. Attempts were made to improve the purification of ORF7 by e.g.
the use of other columns without any significant differences observed.
4.3 Crystallisation of ORF7
Despite impurities,  extensive  crystallisation  screening  of  ORF7  was  performed
using different methods, crystallisation screens and at different temperatures. The
most promising conditions were  found  with  the  hanging  drop  method  at  20°C
with  approximately  2  M  ammonium  sulphate  as  precipitating  agent  and  in
HEPES-buffer  pH  7.5-8.  These  conditions  gave  needle-shaped  crystals  (Figure
4.2).  Further  screening  to  improve  the  needles  was  performed,  many  additives
were tested, and also seeding was  tried.  These  trials  did  not  result  in  dramatic
improvement – the needle-like crystals prevailed  (Figure  4.2).  The needles  were
tested  for  diffraction  at  the  ESRF  but  no  diffraction  was  observed.  No  salt
diffraction was observed indicating that the crystals were indeed protein.
Figure 4.2 Different needle-shaped crystals of ORF7.   
Figure 4.1 A 20% SDS PAGE gel of the
purified  ORF7: lanes 1, 2 and 3 show
the same sample.  Lane  M  is  the  low-
molecular  weight  marker  with  the
molecular weights indicated to the  left
in kDa.44
5. Cephamycin C biosynthesis: the structure and
    function of cmcI (Paper III and IV)
5.1 Background
Cephalosporins and cephamycins differ by a methoxyl group at the C-7α position
of the β-lactam ring (Figure 5.1). This methoxyl group  influences  the  antibiotic
activity spectrum of the molecule and increases its resistance against β-lactamases.
The main focus of this chapter is how this methoxyl group is incorporated into the
cephalosporin molecule in Streptomyces clavuligerus and the role of  the  enzyme
cmcI in this process.
Work  on  cell  free  extracts  of  S.  clavuligerus  has  demonstrated  that  the
methoxylation occurs in two steps, a hydroxylation followed by a methylation of
the hydroxylated intermediate (O'Sullivan & Abraham, 1980; Hood et al., 1983)
(Figure 5.1). The conversion of cephalosporin to cephamycin requires the addition
of Fe(II),  2-oxoglutarate,  S-adenosyl-L-methionine  (SAM)  and  a  reducing  agent
(O'Sullivan & Abraham, 1980; Hood et al., 1983). In the absence of  SAM,  the
hydroxylated intermediate was formed (Hood et al., 1983). Based on these results
it was assumed that the hydroxylation reaction was catalysed by a 2ODD and the
methylation by a SAM-dependent methyltransferase.
Except  for  the  methoxylation,  the  biosynthesis  of  cephamycin  C  from
deacetylcephalosporin C involves a carbamoylation at the C-3 position, catalysed
by DAC-carbamoyl transferase (Coque et al., 1995a). The order of carbamoylation
and methoxylation has not been fully  elucidated  but  it  has  been  suggested  that
carbamoylation  preceeds  methoxylation  (Baldwin  &  Schofield,  1992).  The
methoxylation  has  been  shown  to  occur  using  both  cephalosporin  C  and
carbamoyldeacetylcephalosporin C as substrates (O'Sullivan & Abraham, 1980).
Figure  5.1  Biosynthesis  of  cephamycins  from  cephalosporins  occurs  via
hydroxylation followed by methylation at the C-7α position.
Two  genes,  cmcI  and  cmcJ,  in  the  cephamycin  gene  cluster  of  Streptomyces
clavuligerus  have  been  implicated  in  the  methoxylation  reaction  (Alexander  &
Jensen, 1998). An initial search of these enzymes in protein databases and review
articles  identifies  cmcI  as  the  cephalosporin  hydroxylase  and  cmcJ  as  the
methyltransferase  (Brakhage,  1998;  Elander,  2003).  However,  more  detailed
analysis questions these assignments.
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Sequence analysis shows that the 28 kDa gene product of cmcI has weak sequence
characteristic  of  methyltransferases  and  monooxygenases,  whereas  the  32  kDa
product of  cmcJ shows  weak  sequence  homology  to  a  number  of  hypothetical
proteins and a gibberellin desaturase with hydroxylase activity (Tudzynski et al.,
2003).
Contradictive  results  have  been  published  on  the  enzymes  involved  in  the
methoxylation. The first report described the purification of a  cephalosporin  7α-
hydroxylase  with  an  estimated  molecular  mass  of  32  kDa  from  cells  of  S.
clavuligerus (Xiao et al., 1991). The enzyme  catalysed  the  hydroxylase  reaction
with  the  cofactor  requirements  of  a  2-oxoglutarate  dependent  dioxygenase.  The
first investigation on the genes cmcI and cmcJ came from  Coque  et  al.,  (1995).
Cell-free extracts of S. lividans (not a cephamycin producer) transformed with the
DNA fragments of cmcI and cmcJ from A. lactamdurans were shown to  catalyse
the methoxylation on addition of 2-oxoglutarate  and  SAM.  CmcI alone  showed
weak hydroxylase activity  in  the  presence  of  2-oxoglutarate  or  NADH,  whereas
cmcJ showed  no  activity  by  itself.  Further  studies  involving  immunoaffinity,
protein  cross-linking  and  fluorescence  spectroscopy  (Enguita  et  al.,  1996),
suggested that cmcI  and  cmcJ could  form  a  complex  able  to  perform  both  the
hydroxylation and the methyl transfer reaction with the active site  on  cmcI,  and
cmcJ working as a helper protein.
Taking  all  of  these facts  together  yield  different  theories  on  the  function  and
mechanism of cmcI  and  cmcJ in  the  cephamycin  biosynthesis.  (i)  CmcI  is  the
hydroxylase,  working  as  a  2ODD  or  using  NADH  and  cmcJ  is  the
methyltransferase. (ii) CmcI  is  the  methyltransferase  and  cmcJ the  hydroxylase.
(iii) CmcI and cmcJ form a complex and perform both reactions together. Using a
structural  approach  to  answer  these  questions,  the  structure  of  cmcI  from  S.
clavuligerus was determined and the results will be presented here. The work on
cmcI  can  in  some  aspects  be  compared  to  structural  genomics  projects  where
structures of proteins with unknown functions are determined.
5.2 Expression, purification and crystallisation of cmcI
(Paper III)
5.2.1 Expression and purification
The cmcI gene  of  S.  clavuligerus  was  cloned  into  the  pET32  vector.  In  this
construct, cmcI is fused to thioredoxin, which in turn is labelled with a His-tag.
The plasmid  was  transformed  into  E.  coli  and  expressed  at  a  high  yield.  The
purification involved separation on a nickel affinity column, followed by removal
of the thioredoxin tag by cleavage with factor Xa. The His-tagged thioredoxin was
separated from cmcI using Ni-NTA beads, and the factor Xa was  removed  using
benzamidine Sepharose beads. The remaining cmcI  was  further  purified  using  a46
gelfiltration column. This procedure  yields  very  pure  cmcI  without  any  tags  or
extra residues attached.
The initial clone of cmcI (paper III) was discovered to have three differences at the
amino acid  level,  L10Q,  D160N  and  L200F,  compared  to  the  sequence  in  the
Genbank (Alexander & Jensen, 1998).  It  was  not  immediately  obvious  whether
these differences arose from PCR  errors, sequencing errors, the  presence  of  cmcI
isoforms  or  different  strain  origins  because  at  least  one  of  the  differences  was
encountered when cmcI  was  independently  recloned.  Further  recloning  indicated
that the alterations at position 10 and 160 were mutations caused by PCR  errors
whereas  no  such  indication  was  found  at  position  200.  Multiple  sequence
alignments using Clustal-W (Paper IV) further indicated that residue  160  should
be an aspartic acid, since it is highly conserved and the structure of cmcI revealed
it to be located in the active site.
Therefore, a new expression plasmid  was  generated  by  site-directed  mutagenesis
for production of ‘native’ cmcI which  differes  from  the  Genbank  sequence  by  a
phenylalanine  instead  of  leucine  at  position  200.  This  plasmid  was  used  to
produce protein for the majority of the structural studies and the product is referred
to as cmcI-D160.  The product of  the  original  construct  is  referred  to  as  cmcI-
N160.
5.2.2 Crystallisation
The first crystals of cmcI-N160 appeared in PEG 4000, sodium  acetate  and  Tris
buffer, were box-shaped and did not diffract. Further screening in the presence of
2-oxoglutarate, a cofactor for 2ODDs, yielded needle-shaped crystals alongside the
box-shaped ones in the same conditions (Figure 5.2). The needle-shaped  crystals
diffracted to around 2.5 Å resolution.
The  crystallisation  conditions  used  for  cmcI-N160,  only  produced  very  thin
needles of cmcI-D160 protein that were not suitable for data collection. Screening
for new conditions yielded crystals in the presence of magnesium chloride instead
of sodium acetate and either PEG 4000, or a mixture of PEG 8000/PEG 1000 or
PEG  20000/PEG  550.  2-oxoglutarate  was  not  necessary  to  obtain  the  needle-
shaped crystals of cmcI-D160.
Figure 5.2  Crystallisation
of  cmcI-N160  in  the
presence of 2-oxoglutarate
gave  two  crystal  types:
box-  and  needle-shaped
crystals, of which only  the
needle-shaped  crystals
diffract.
Figure 5.3
Crystallisation of cmcI in
the presence of 2-
oxoglutarate gave two
crystal diffract.47
5.2.3 Different crystal forms of cmcI
Morphologically  similar  crystals (needle-shaped)  of  cmcI  have  been  shown  to
belong to two different space groups: P21 and P212121. The orthorhombic crystals
gave  rise  to  two  different  unit  cells  (Table  5.1).  There  is  no  difference  in
diffraction limit (~2.5-3 Å) and  the  solvent  content  is  very  similar  in  all  three
crystal types.
Table 5.1 The different crystal forms observed for cmcI.
Space group Cell  dimensions         Solvent content Nr of molecules in a.u
             a,b,c, β
    P21 ~ 93, 183, 103 Å, ~91° 55 %   12
     P212121 ~ 93, 103, 183 Å 53 % 6
 P212121         ~ 78, 145, 162 Å 58 %     6
The crystal structure revealed the same hexameric arrangement of cmcI in all three
crystal forms. The differences between the crystal forms are caused by the altered
packing of the hexamers relative each other, whereas the hexamer itself seems  to
form a rigid unit.
5.3 Crystal packing and oligomeric state of cmcI in solution
Judging by the first native data  set  collected  on  cmcI-N160,  a  large  number of
molecules of  cmcI  were  indicated  to  be  present  in  the  asymmetric  unit.  This
conclusion was based on the relatively large cell dimensions for a protein with a
molecular weight of 28 kDa (space group P21, cell dimensions ~93, 183 and 103
Å  and  a  β-angle  of  91°).  Unambiguous  determination of  the  packing  and  the
number of molecules in the asymmetric unit was not possible by calculations of
the  Matthews  coefficient,  VM  (Matthews,  1968),  and  solvent  content.  The
differences between the values were very small and it appeared that there could be
anything between 8 and 18 molecules present in the asymmetric unit  (Table 5.2).
Table 5.2 VM and solvent  content  as  a  function  of  the  number  of  molecules  in  the
asymmetric unit for the monoclinic space group  of cmcI. For most protein  crystals  VM
is usually between 1.7-3.5 Å
3/Da with a mean value around  2.15 Å
3/Da and the solvent
content is normally between 30-60% for a soluble protein (Drenth, 1994).
Nr of molecules in the a.u VM     Solvent content
(Å
3/Da) (%)
 8       4.1     69.6
 9       3.6 65.8
    10       3.3 62.0
11   3.0     58.3
12   2.7     54.5
13   2.5     50.7
14   2.3     46.9
15   2.2     43.1
    16   2.0     39.3
17   1.9 35.5
18   1.8     31.748
To  determine  the  oligomeric  state  of  cmcI  in  solution,  a  number  of  different
methods  were  used.  Gel  filtration  analysis  indicated  that  cmcI  formed  at  least
trimers, and similar results were obtained from native gel analysis. Dynamic laser
light scattering showed  a  monomodal  distribution  with  an  estimated  weight  of
around 180-200 kDa, depending on the temperature. Evidence for a hexamer was
obtained  from  “native”  (i.e.  soft  ionization)  electrospray  ionization  mass
spectrometry, which also showed monomers and dimers (Paper III). However, the
appearance of the hexamer seemed to be dependent on the salt concentration of the
sample. At 10 mM ammonium acetate pH 7 no hexamer was detected, whereas at
50  mM  salt  concentration  a  mixture  of  monomers,  dimers  and  hexamers  was
observed. At even higher buffer concentrations no signal at all could be detected.
The self-rotation function (Paper III) showed two peaks in  the  χ  =  60°  section.
These could either correspond to two sixfold axes or two threefold axes parallel to
two twofold axes. Both options corresponds to 12 molecules in  the  asymmetric
unit.
Taking all these facts together presented convincing arguments for the presence of
twelve  molecules in  the  asymmetric  unit  in  the  monoclinic  crystals,  probably
derived  from  two  hexamers,  with  one  hexamer  in  the  asymmetric  unit  of  the
orthorhombic crystals. This was corroborated from the structure of cmcI showing a
hexameric arrangement.  
5.4 Structure determination
At an early stage, significant non-isomorphism between the crystals of cmcI was
detected, this was also the case for crystals of the  same crystal  form.  Therefore,
phasing  with  anomalous  scatterers  was  recognised  to  be  required.  Extensive
soaking  and  co-crystallisation  with  a  number  of  different  heavy  atoms  were
performed  and  several  MAD  and  SAD  data  sets  were  collected  at  the  suitable
wavelengths. However, none of these datasets produced high enough anomalous or
dispersive signals to locate any heavy atom sites.
Selenomethionine substituted cmcI was produced (Budisa et  al.,  1995)  and  was
purified in a similar fashion as the unsubstituted protein, except including 10 mM
β-mercaptoethanol  in  all  buffers  and  adding  a  last  desalting  step.  The  100  %
incorporation  of  selenium  was  confirmed  by  mass-spectrometry.  Crystals  of
selenomethionine-labelled cmcI-N160 were grown in similar conditions as  native
cmcI-N160,  including  5  mM  β-mercaptoethanol.  Since  cmcI  contains  ten
methionines out of 236 amino acids, a high anomalous contribution, sufficient to
solve the structure, was expected.
Despite collecting a number of MAD- and (highly redundant) SAD  data  sets  on
selenomethionine-labelled  cmcI,  the  structure  could  not  be  solved.  The  X-ray
fluorescence absorption spectrum of the frozen  crystals produced  high  signals  at
the selenium K-edge, but the anomalous and dispersive signals from the data sets49
were weak and never extended beyond 4-5 Å resolution. Due to the weak signals,
the selenium sites  were  difficult  to  locate.  Considering  the  many  molecules of
cmcI  in  the  asymmetric  unit  and  the  presence  of  ten  methionines  in  each
monomer, a large number of selenium sites were expected, 60 in the orthorhombic
space group and  120  in  the  monoclinic  case.  To  locate  the  sites,  a  number of
different programs were tried in particular Solve (Terwilliger & Berendzen, 1999),
SHELXD (Schneider & Sheldrick, 2002) and SnB (Smith et al., 1998). These are
powerful  programs  and  have  successfully  been  used  to  locate  high  numbers  of
anomalous scatterers (Deacon & Ealick, 1999).
The absorption edge from the fluorescence scans had a ‘smeared’ appearance, which
could  be  due  to  a  mixture  of  oxidised  and  reduced  seleniums  in  the
selenomethionine substituted  crystals.  A  sharp  absorption  edge  is  preferred  to
accurately  determine  the  wavelengths  corresponding  to  the  peak  and  inflection
points. To assure that only one oxidation species was present in the crystals at one
time, attempts were made to fully oxidise the seleniums using hydrogen peroxide
(Sharff et al., 2000) or fully reduce them with dithiothreitol (DTT) (Thomazeau et
al., 2001).  However,  this  did  not  result  in  significant  differences  either  in  the
shape of the absorption edges from the scans or in the strength of the anomalous
signals of the collected data.
A  data  set  collected  at  beam  line  ID29  at  ESRF  finally  yielded  the  structure
solution from a selenomethionine crystal that was not exposed to either hydrogen
peroxide  or  DTT.  The  crystal  belonged  to  space  group  P212121  with  cell
dimensions  92.8,  103.0  and  182.0  Å  (Paper  IV).  Data  were  collected  at  three
wavelengths, but due to radiation damage, only 400° of  the  peak  data  could  be
used. These data were scaled to 3.6 Å resolution and treated as a SAD  data  set.
Compared  to  the  previously  collected  data  sets,  this  data  set  showed  stronger
anomalous signal and the signal was present to higher resolution.  To  locate  the
large  number  of  selenium  sites,  a  new  program,  Hybrid  Substructure  Search
Procedure (HySS) was used (Grosse-Kunstleve & Adams, 2003). The present data
set with its many anomalous scatterers provided a suitable test case  for  program
development  (Grosse-Kunstleve,  personal  communication).  52  Sites  out  of  60
possible were found with a correlation coefficient of 41%. A crucial ingredient for
the substructure determination was to cut the data at 3.8 Å, including the data to
3.6 Å did not work. The reason for this  is  not  entirely understood,  the  data  is
100%  complete  at  3.6  Å  and  the  anomalous  signal  is  only  slightly  reduced
between 3.8 and 3.6 Å.
The 52 initial  sites  were  fed  into  SHARP  (La  Fortelle  &  Bricogne,  1997)  for
initial phasing. After removing and adding a few sites, 55 sites were used for final
phase calculations, and the resolution was extended to 3.6 Å. Out of the 55 sites,
one was later recognised as a false site, this meant that all seleniums except the N-
terminal selenomethionines were located. The phases were subsequently improved
by density modification procedures to give an excellent and interpretable electron
density  map.  The  map  was  further  improved  by  exploiting  the  6-fold  non-
crystallographic symmetry (NCS) of the asymmetric unit.  An  initial  model  was
built into the 3.6 Å resolution map (Figure 5.3), comprising residues 9-230 (out50
of  236  in  total).  This  model  was  refined  using  NCS  Phased  Refinement  in
CCP4i, a program that cycles between Refmac5 (Murshudov et al., 1997) and DM
(Cowtan, 1994), which in turn uses the 6-fold averaging for map improvement.
Figure 5.3 Stereoview of part of the initial  electron  density  map at 3.6 Å with parts of
the final Cα model overlaid.  The electron  density  map was calculated  with the phases
derived from SAD phasing  after density  modification  and 6-fold  local averaging.  The
2mFobs-DFcalc is contoured at 1.0 σ where σ is the root  mean square electron  density  for
the unit cell.
By using data from a cmcI-N160 crystal, the  resolution  was  extended  to  2.5  Å
(Paper IV). This  crystal  belonged  to  the  monoclinic  space  group  P21,  therefore
molecular replacement was used with  the  hexamer  as  the  search  molecule.  This
model  was  initially  refined  using  the  NCS  phased  refinement  with  12-fold
averaging. Model building  was  cycled  with  maximum  likelihood  refinement  in
Refmac5  (Murshudov  et  al.,  1997)  using  strong  NCS  restraints,  which  were
gradually  relaxed.  The  NCS  restraints  were  abandoned  in  the  last  stages  of
refinement and TLS parameter refinement with each monomer as a TLS group was
implemented. The final model has an Rcryst of 18.9% and an Rfree of 24.6%.
5.5 The structure of cmcI (Paper IV)
5.5.1 The monomer
The structure of cmcI revealed a cmcI monomer (Figure 5.4a) built up from an N-
terminal domain involved in oligomerisation, and a C-terminal domain containing
the proposed active site. The C-terminal domain, comprising amino acid residues
67-236,  consists  mainly  of  a  modified  Rossmann-like  fold  (Rossmann  et  al.,
1974) built up from a central parallel six-stranded β-sheet (β4-β9) extended by one
anti-parallel strand (β10). A total of seven helices pack against the  central  sheet.
The N-terminal domain,  comprising  amino  acid  residues  1-67,  contains  mainly
loop structure but also two short α helices (α1 and α2), two small anti-parallel β51
strands (β2-β3), and one β strand (β1) that forms  an  extension  of  the  central  β-
sheet of the C-terminal domain of an adjacent molecule.
5.5.2 Quaternary structure
The N-terminal domain of cmcI is involved in extensive oligomerisation, forming
two  types  of  interactions  with  neighbouring  molecules.  Type  one  interaction
involve residues 24-59 from one molecule that pack against the α3-, α8- and α9-
helices and the loop comprising residues 215 to 226 of an adjacent molecule. An
extension of the central β-sheet is formed by the interaction of the β1-strand of one
molecule with the β9-strand of the adjacent  molecule  and  vice  versa,  to  form  a
dimer (Figure 5.4c). Except for the interactions from the N-terminal domain, there
are also further tight interactions between the two monomers involving helices α3
and α4 from both monomers.
In the second type of interaction, residues 1-20 interact with a third molecule by
packing against the helices α7, α8 and α9 and vice versa (Figure 5.4d). The type
two interactions are weaker than  the  type  one  interactions,  because  the  interface
contains a large cavity that harbours the putative active site.
The oligomerisation is repeated cyclically and results in a hexameric arrangement
of the molecules, where each molecule interacts with two neighbouring molecules
(Figure 5.4e). The hexamer can be described as a dimer of trimers or a trimer of
dimers and has the shape of a puckered doughnut, with a diameter of 100 Å in the
widest dimension and 50 Å in the narrowest. In the middle of the hexamer  is  a
solvent channel with a diameter of around 30 Å.
5.5.3 Structural alignment comparisons
When a structure of a protein with unknown function has been solved, structural
comparison  to  the  PDB  database  using  a  protein  fold  comparison  server  is  an
obvious approach to obtain information about the protein. Using the DALI server
(Holm & Sander, 1993), a high structural homology of cmcI with small-molecule
SAM dependent methyltransferases was found (Paper IV), with the  most  similar
structure  identified  as  cathechol  O-methyltransferase  (COMT)  (Vidgren  et  al.,
1994). Dividing cmcI into N- and  C-terminal  domains  and  searching  with  each
domain separately gave the same result for the C-terminal domain as for the whole
monomer, whereas no similar structures were found with the N-terminal domain.
Structural  similarity  of  cmcI  to  NAD-dependent  dehydrogenases  was  also
observed.  For  both  methyltransferases  and  dehydrogenases,  the  Rossmann  fold
domains overlap with cmcI and the nucleotide binding is positioned on the top of
the Rossmann fold in these enzymes (Figure 5.5 and 5.7).
The structural  similarity  of  cmcI  to  methyltransferases  and  dehydrogenases  is
interesting from a functional aspect. A methyltransferase has been proposed to be
part of the methoxylation reaction and NADH stimulated hydroxylase activity has
been reported (Coque et al., 1995b).
 52
A B
C D
E
Figure 5.4 (A)-(E) Legend opposite.
α3
α2
C
α4 α7
α8
α9
β3
β4 β5 β6 β7 β8 β10
N α1
β1
α5
β2
β9
12 15
35 37
38 43
57 58
61 62
67
80 84
88 94
105 111
116 126
128 132
136 143
146 155
159 165
175 182
185
189 195
197
205 211
214 228
231
α653
Figure  5.4  The  structure  of  cmcI.  (A)  Ribbon  diagram  with  secondary  structure
elements colour ramped from blue to red by sequence from the N to the C terminus.  (B)
Topology  diagram with the α-helices  and β-strands  labelled  and  coloured  green  and
blue  respectively.  (C) Type one interactions  between subunits.  The two monomers  in
the dimer are in red and blue, and a third  monomer  (yellow)  in  the  background.  (D)
Type two interactions  between subunits  (in  blue  and  yellow)  with  a  third  monomer
(red) in the background. (E) The hexamer of cmcI with the same colour  coding  as in C
and D.
5.6 Complexes of cmcI
To further investigate the possible function of cmcI, crystals of complexes with a
number of  different  cofactors  were  obtained  by  co-crystallisation.  The cofactors
were  chosen  by  consideration  to  the  different  available  theories  on  cephamycin
biosynthesis.
5.6.1 Iron and 2-oxoglutarate
With  respect  to  the  proposal  of  a  2-oxoglutarate  dependent  dioxygenase  in  the
cephamycin biosynthesis and the assignment in protein databases of cmcI for this
function, thorough investigation of this possibility was made. Comparison of the
structure of cmcI to structures of 2ODDs, did not detect similarity to the common
jelly roll fold of 2ODDs. 2ODDs have been shown to  use  a  conserved  2-His-1-
carboxylate triad motif to bind the iron (Hegg &  Que,  1997).  Inspection  of  the
cmcI structure, did not  reveal  a  corresponding  iron  binding  motif.  Attempts  to
obtain activity of cmcI in the presence of Fe(II) and 2-oxoglutarate with or without
SAM or SAM/Mg
2+ was unsuccessful.
Attempts to co-crystallise and soak cmcI-N160 crystals with iron in an anaerobic
box was performed, but did not result in specific iron binding. Co-crystallisation
of cmcI-D160 in the presence of iron instead of magnesium in the anaerobic box
produced thin needle-shaped crystals that were not suitable for data collection. In
this case,  one  can  suspect  the  iron  probably takes the  position  of  the  missing
magnesium ion.  
From  the  structure  of  cmcI  it  is  likely  that  cmcI  is  not  the  reported  2ODD
involved in cephamycin biosynthesis and therefore the assignment of cmcI as the
cephalosporin hydroxylase in protein databases is misleading!
5.6.2 SAM/SAH binding
Co-crystallisation of cmcI-N160 and D160 (paper IV) with SAM resulted in SAM
binding  to  cmcI  at  a  position  corresponding  to  the  binding  site  for  SAM  in
methyltransferases,  overlapping  with  the  SAM  binding  site  in  COMT  (Figure
5.5).  The  SAM  binding  site  is  located  in  a  similar  position  in  all  known
methyltransferases  although  the  residues  that  bind  SAM  are  poorly  conserved54
(Martin & McMillan, 2002). In cmcI, SAM is bound by a extensive network of
hydrogen bonds and hydrophobic interactions.
A structure of cmcI-N160 in complex with S-adenosyl-L-homocysteine (SAH), the
demethylated product of SAM, was also obtained (paper IV). The position of the
SAH molecule and all interactions to the protein residues are identical to those in
the SAM complex.
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5.6.3 Magnesium binding and the importance of Asp160
A dramatic difference in the crystallisation conditions of cmcI-D160 compared to
cmcI-N160 was observed, see section 5.2.2.  It was found that cmcI-D160 crystals
were only formed in the presence of Mg
2+.
In the structures of cmcI-D160 and the SAM-complex of cmcI-D160 (paper IV), a
new density, which was modelled as a magnesium ion, appeared in the active site,
close to the SAM binding position (Figure 5.6). The magnesium ion is ligated by
Figure  5.5  (A)  Stereoview  of  SAM
binding  to cmcI with SAM  carbons
in green. The 2mFobs-DFcalc electron
density  map  is  contoured  at  1.0  σ
where  σ  is  the  root  mean  square
electron  density  for  the  unit  cell.
(B) Structural superposition of  cmcI
(blue) and COMT (orange) showing
the  positions  of  respective  SAM
molecule,  SAM-cmcI  (dark  blue)
and SAM-COMT (red).   55
Asp160,  Glu186  and  Asp187.  The  position  of  the  ion  corresponds  to  the
magnesium  binding  site  in  COMT,  the  methyltransferase  identified  as  most
structurally similar to cmcI. The magnesium ion is crucial  for  substrate binding
and catalysis in COMT (Vidgren et al., 1994), and it seems plausible that it plays
a similar role in cmcI. Attempts have been made to co-crystallise and soak cmcI-
N160 crystals with magnesium but no magnesium binding was  obtained,  which
points to the importance of Asp160 in binding the ion. The corresponding ligand
in COMT is Asp141.   
Additional density, shaped as two elongated cylinders was observed close to  the
magnesium ion in the structures of cmcI-D160. Two PEG molecules with a length
of  4  and  12  carbons,  respectively,  were  modelled  into  the  density.  The  PEG
molecules are  positioned  in  the  cavity  between  two  monomers  on  a  two-fold
symmetry axis. This is shown in Figure 5.6. The longer PEG extends all the way
from the active site of one molecule to the active site of the other molecule. In the
cmcI-D160 SAM complex, the density for both the magnesium ion and the PEG
molecules is  stronger  compared  to  the  structures  lacking  SAM,  and  the  longer
PEG molecule is extended by two carbon-units and  ligates  the  magnesium  ions
directly (Figure 5.6). The PEG binding site overlaps  with  the  substrate binding
site in COMT and is likely to  correspond  to  the  substrate binding  site  also  in
cmcI. In the cmcI-N160 structures that do not bind magnesium ions, no  density
for PEG is present.
Figure 5.6 Stereoview showing the binding of magnesium  and PEG in the structure  of
cmcI-D160-Mg
2+-SAM. One Mg
2+ binds per subunit, and PEG (modelled as one 4-C unit
and one 14-C unit)  binds  in the cavity  between the two monomers  coloured  blue  and
yellow. PEG carbons are grey, the SAM molecules  are green, and the Mg-ions  are grey
spheres. The 2mFobs-DFcalc electron density map at the PEG molecules  is contoured  at 1
σ where σ is the root-mean square electron density for the unit cell.56
5.6.4 NADH binding
Co-crystallisation of cmcI-N160 and  -D160  with  20  mM  NADH  (Appendix  A)
produced significantly different structures. In the cmcI-N160 structure, density for
NADH was observed in the cavities between the molecules, resulting in only three
molecules of NADH bound in the hexamer of cmcI (Figure 5.7). The binding does
not correspond to the expected binding mode of  NADH  to  a  nucleotide-binding
motif (Figure 5.7) and does not coincide with the SAM binding but overlaps with
the  observed  PEG  binding.  The  density  corresponds  to  the  central  ribose-
phosphate moiety of the NADH molecule, whereas there is only weak density for
the   nicotinamide and adenine parts.
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Figure 5.7 The binding of NADH to cmcI-N160. (A) Stereoview showing NADH binding
with one cmcI molecule in dark grey and the other molecule  in light  grey. The 2mFobs-
DFcalc electron density  around  the NADH molecule  is contoured  at 1 σ, where σ is the
root mean square electron density for the unit cell. (B) Overview showing  one hexamer
with three bound  NADH molecules  as black spheres. (C) Superposition  of cmcI (light
grey)  with  human  alcohol  dehydogenase  (dark  grey)  (pdb-id  1agn)  showing  the
positions  of  the  respective  NADH  molecules,  NADH-cmcI  (grey)  and  NADH-alcohol
dehydrogenase (black).57
In sharp contrast, the structure of cmcI-D160 co-crystallised with NADH does not
show  NADH  bound.  Instead,  continuous  density  for  PEG  is  observed  at  the
corresponding NADH binding site. Because of the unusual binding of NADH in
the cmcI-N160 structure and the lack of NADH binding to the cmcI-D160 enzyme,
it seems unlikely that the NADH binding is of functional significance, but rather
reflects a structural role of NADH and the capacity of cmcI to bind large ligands in
this cavity.
5.6.5 Docking of substrate
Despite  persistent  trials  to  co-crystallise  cmcI  with  different  cephalosporins,
cephalosporin  C,  O-carbamoyl  deacetoxycephalosporin  C  and  7-methoxy
cephalosporin  C,  density  for  the  cephalosporins  were  not  detected  in  electron
density maps of the corresponding structures. This is probably due to the bound
PEG molecules, which interfere with the substrate binding.
Docking of O-carbamoyl-deacetylcephalosporin C to the refined structure of cmcI-
D160 in complex with  magnesium  and  SAM  was  performed  using  AutoDock3
(Morris et al., 1998) (paper IV). The docking procedure consists of the generation
of a grid of affinity potentials that represent the shape and electrostatic properties
of the active site. As a starting point, a very large grid covering the whole cavity
between two molecules was chosen. The docked conformations showed one minor
cluster of conformations. The position of these conformations was used to create a
more size-restricted grid. Docking of the molecule into this grid resulted in only
one cluster of molecules (cluster cut-off r.m.s. deviation <1.5 Å).
The  position  and  conformation  of  the  docked  molecule  (Figure  5.8)  makes
chemical  sense  if  cmcI  is  a  methyltransferase.  The methyl  group  on  the  SAM
molecule  is  in  a  position  where  it  could  be  transferred  to  the  cephalosporin
molecule, and the modelled  cephalosporin  overlaps  with  the  bound  competitive
inhibitor in the structure of COMT (Vidgren et al., 1994). The carbonyl oxygen of
the β-lactam ring is at a distance of 3 Å to the magnesium ion. This positions C7
at a distance of over 5 Å to the methyl group of the SAM molecule, but with a
hydroxyl group at the C7α, the distance is shortened to ~3.5 Å and the orientation
could allow a  methylation  reaction  to  take  place.  The adipyl  side  chain  of  the
cephalosporin molecule occupies the binding site of the longer PEG molecule in
the crystal structure (Figure 5.8b). Several protein residues (Ser54, Tyr56, Asp66
and Gln223) are within van der Waals/hydrogen bonding distance to the carbamoyl
side chain.58
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5.7 The function of cmcI
From  what  was  known  about  the  methoxylation  reaction  in  the  cephamycin
biosynthesis before this project was started, three main theories on the function of
cmcI and cmcJ could be  formulated:  (i)  CmcI  is  the  cephalosporin  hydroxylase
using  2-oxoglutarate  or  NADH  as  electron  donor,  and  cmcJ  is  the
methyltransferase. (ii) CmcJ  is  the  hydroxylase  and  cmcI  the  methyltransferase.
(iii) CmcI and cmcJ form a complex and perform both reactions together with the
active site on cmcI  and  cmcJ working  as  a  helper  protein.  By  determining  the
structure of cmcI alone and in complex with cofactors at least one of these theories
can be ruled out and the knowledge about cephamycin biosynthesis and the role of
cmcI has increased dramatically.
Figure 5.8 (A) Stereoview of the
docked O-carbamoyl-deacetyl-
cephalosporin C (in magenta) in the
active site of cmcI with residues
from one monomer in blue and from
the second in yellow. The SAM
carbons are in green and the Mg
2+
ion is a grey sphere. (B) The model
of O-carbamoyl-deacetyl-
cephalosporin C superimposed on
the structure of cmcI-Mg
2+-SAM
with bound PEG (carbons in grey).59
Since the structure of cmcI bears no similarities  to  the  family  of  2-oxoglutarate
dependent  dioxygenases,  neither  in  the  fold  nor  in  the  important  iron-binding
motif,  it  seems  unlikely  that  cmcI  would  function  as  a  2ODD.  The  structural
similarity  to  NAD-dependent  dehydrogenases  points  to  a  much  more  likely
mechanism  if  cmcI  is  the  hydroxylase.  However,  the  unusual  and  probably
unproductive binding of NADH, also rules this function out.
In respect to a hydroxylase function of cmcI, two other more “exotic” mechanisms
have been considered. One is based on the structural similarity to aclacinomycin-
10-hydroxylase  from  S.  pururascens  (Paper  IV)  (Jansson  et  al.,  2003).
Aclacinomycin-10-hydroxylase  has  the  fold  of  a  methyltransferase  and  binds
SAM/SAH in the common binding site for these enzymes  but  the  enzyme  is  a
hydroxylase  and  requires  SAM,  molecular  oxygen  and  a  reducing  agent  for
activity.  This  mechanism  is  unlikely  in  light  of  the  suggested  cofactor
requirements for 7α-cephem hydroxylation.  The other mechanism considered  in
the  aspect  of  SAM  binding  to  cmcI,  is  the  possibility  of  cmcI  to  be  a  SAM
dependent radical enzyme (Layer et al., 2004). These enzymes require an essential
Fe4S4 cluster coordinated by a characteristic CxxxCxxC sequence motif (C, Cys; x
any  amino  acid).  The  absence  of  these  features  in  cmcI  argues  against  this
mechanism here. However, other types of reactions with one-electron donors that
may lead to radical formation on SAM may be possible.
Based on the structural investigations and activity measurements on cmcI, theory
number one can be ruled out. This is a significant finding since cmcI and cmcJ are
assigned the respective roles as cephalosporin hydroxylase and methyltransferase in
the different protein databases. This could serve as a lesson that the annotations of
proteins should not be  trusted  without  further  studies  confirming  the  literature.
Unfortunately,  several  recently  sequenced  proteins  from  the  big  genome
sequencing  projects  have  been  discovered  to  have  putative  functions  as
cephalosporin  hydroxylases  and  methyltransferases  based  on  their  sequence
similarities to cmcI and cmcJ, respectively. This could add a lot of confusion and
unnecessary work in future research and the mistakes could take long to repair.
The structural similarity  of  cmcI  to  SAM-dependent  methyltransferases,  also  in
respect  of  SAM/SAH  binding,  indicates  cmcI  as  the  methyltransferase  in  the
cephamycin  biosynthesis.  The magnesium  ion  is  bound  to  cmcI  at  the  same
position as the crucial magnesium ion in  COMT.  The docking  of  the  substrate
analogue  O-carbamoyl-deacetylcephalosporin  C  to  cmcI  further  supports  this
theory since the docked conformation of the molecule places the C-7 position of
the cephalosporin molecule in a way that would allow a methyltransfer from  the
bound  SAM  molecule  to  the  cephalosporin.  This  could  explain  the  lack  of
observed activity of cmcI to  cephalosporin  substrates  that  lack  the  7α-hydroxyl
group. There are no 7α-hydroxyl cephalosporins commercially available, these are
labile  compounds  that  are  very  difficult  to  synthesize.  Methyltransferases
commonly  form  oligomeric  structures,  predominantly  dimers  and  tetramers,
however  at  least  two  structures  of  hexameric  methyltransferases  (Weiss  et  al.,
2000;  Tanaka  et  al.,  2004)  have  been  reported.  In  most  small  molecule60
methyltransferases, the N terminus is involved in the oligomerisation and this is
also observed in cmcI.
If cmcI catalyses the methyl transfer reaction, the hydroxylase reaction  would  be
left to be catalysed by cmcJ.  Not  much  is  known  about  cmcJ.  It  shares  a  low
sequence homology with a gibberellin desaturase that has documented hydroxylase
activity (Tudzynski et al., 2003). Both cmcJ and the gibberellin desaturase have a
HXD motif, which is part of the characteristic 2-His-1-carboxylate triad motif that
ligates  the  iron  in  2ODDs.  In  addition,  the  molecular  weight  of  the  purified
cephalosporin  hydroxylase  reported  by  Xiao  et  al.(1991)  corresponds  to  the
molecular weight of cmcJ.
Hexameric methyltransferases have been  reported,  however  there  is  a  possibility
that the observed hexameric arrangement of cmcI, in solution and in  the  crystal,
may be an artefact caused by the high concentration of cmcI and possibly the lack
of cmcJ. The stabilisation gained from the interaction with two adjacent molecules
of  cmcI  in  the  hexamer,  could  be  provided by  cmcJ resulting  in  a  cmcI/cmcJ
complex  that  could  catalyse  the  hydroxylase  and  methyltransfer  reaction  in  the
same active site as suggested  (Coque  et  al.,  1995b;  Enguita  et  al.,  1996).  The
monomer of cmcI in the present structure with a long excursion of the N terminal
domain  is  unlikely  to  exist  as  a  soluble  entity  on  its  own.  Without  further
experimental  proof,  the  theory that  cmcI  and  cmcJ form  a  complex  cannot  be
excluded.61
6. Future perspectives
Are there ever any finished projects in science? I don’t think so and with respect to
the  projects  discussed  in  this  thesis  many  questions  remain  or  new  ones  have
emerged from this work. Some of the most important aspects  will  be  discussed
below.
6.1 Deacetoxycephalosporin C Synthase
When I started my PhD one of the goals was to catch a 3-D structure of the ferryl
intermediate of DAOCS. To do this a non-twinned crystal form was needed! The
plan was to expose reduced DAOCS-Fe(II)-2-oxoglutarate crystals with oxygen in
a controlled manner. From experience of work in the lab on horseradish peroxidase
(Berglund et al., 2002), the crystals were expected to be reduced in the x-ray beam
upon data collection and the  plan  was  therefore  to  merge  the  data  from  several
different crystals, only collecting a few degrees on each crystal. This would not be
possible using the twinned R3 crystal form of DAOCS since each crystal would
have  a  different  degree  of  twinning  resulting  in  large  errors  on  scaling.
Unfortunately, the new non-twinned crystal form did not diffract to high enough
resolution to be able to detect the small differences caused by ferryl formation at
the iron, especially considering the problem of bound cryo-protectant. However, to
catch the ferryl intermediate would still be a very interesting project!
With respect to the importance of  the  C  terminus  of  DAOCS,  a  complex  with
bound  substrate or  product with  a  visible  free  C  terminal  tail  would  be  very
interesting to obtain. Co-crystallisation of His-tagged DAOCS in an anaerobic box
in the presence of iron, 2-oxoglutarate and substrate might be the way  to  obtain
this. However, crystal form II only grow in the cold-room at a temperature of 4°C.
This would introduce the additional problem of  how  to  cool  the  sample  in  the
anaerobic box.
6.2 ORF7
A  key  to  success  in  this  project  seems  to  be  improved  purity  of  ORF7.  The
purification has been  altered  in  a  number of  ways.  Re-cloning  to  add  a  tag  to
simplify  the  purification  has  been  attempted.  Unfortunately,  no  expression  or
insoluble protein was the outcome of these experiments.
ORF15, the homologue to ORF7 with 48 %  sequence  identity  has  successfully
been  crystallised  in  our  lab.  Native  data  has  been  collected  and  phase
determination is  under  way.  The structure  of  ORF15  will  most  probably shed
light  on  the  function  of  both  ORF7  and  ORF15  in  the  clavulanic  acid
biosynthesis.  However,  since  both  the  orf7  and  orf15  genes  are  crucial  for
clavulanic acid production and cannot replace each other, structural investigations
and comparisons of both proteins would be highly interesting.62
6.3 CmcI
Many  important  and  basic questions  remain  to  be  answered  to  understand  the
biosynthesis  of  cephamycin  C.  Is  cmcI  the  methyltransferase  and  cmcJ  the
hydroxylase and do the enzymes work separately  or  in  a  complex?  What  is  the
function of the hexamer of cmcI? Do cmcI and cmcJ work together in a complex,
performing both reactions?
These  questions  can  best  be  answered  by  activity  assays  of  the  two  enzymes,
together and separately. The activity studies  so  far  performed  on  cmcI  failed  to
detect activity. It is impossible to know if this depends on lack of substrate, lack
of cmcJ or inactive cmcI. Attempts are under way to express cmcJ on its own and
to co-express cmcI and cmcJ.63
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Appendix A
Data collection and refinement statistics for the cmcI crystal structures described in
chapter 5 and not included in paper IV. Quality checks performed on the structures
using PROCHECK show good geometry and good agreement between model and
data. The structures features the same cis-peptide and Ramachandran outliers as the
structures presented in paper IV.
                                           cmcI-N160 NADH     cmcI-D160 NADH 
Data collection
Beam line of ESRF ID14EH2 ID14EH2
Wavelength (Å) 0.933 0.933
Space group P212121 P212121
Cell dimensions (Å) 93.7, 102.8, 182.9 95.1, 103.6, 183.0
Resolution range (Å) 91.3-2.50 91.3-2.60
outer shell (Å) 2.59-2.50 2.29-2.60
No. of observations 1543023 1010907
No. of unique reflections 62266 56812
Redundancy 10 7
I/σ(I)
a 34 (2.8) 18 (2.4)
R-merge (%)
b 7.4 (29) 8.0 (31.5)
Completeness (%) 98.5 (88.4) 98.6 (89.5)
Refinement
Residues in model 1388 1385
Number of solvent molecules 713 263
Wilson B-factor (Å
2) 64 56
Rcryst
c 21.1 22.3
Rfree
c 25.5 27.1
r.m.s.d from ideal geometry
bond lengths (Å) 0.0010 0.009
bond angles (°) 1.23 1.20
a Number in parentheses is for the outer resolution shell.
b R-merge =  Σhkl Σi | Ii(hkl)-<Ii(hkl)>|/ Σhkl Σi Ii(hkl), where Ii(hkl) is the intensity  of the
ith observation and <Ii(hkl)> is the mean intensity of reflection hkl, respectively.
c R = Σhkl | |Fo| – |Fc| | / Σhkl |Fo|, where Fo and Fc are the observed  and calculated  structure
factor amplitudes, respectively.